| 1 | Point-of-care testing: state-of-the art and perspectives | 2.3 | 84 | Citations (PDF) |
| 2 | EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) survey on cybersecurity | 2.3 | 4 | Citations (PDF) |
| 3 | EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) recommendations for reinforcing cyber-security and managing cyber-attacks in medical laboratories | 2.3 | 6 | Citations (PDF) |
| 4 | Advancing value-based laboratory medicine | 2.3 | 15 | Citations (PDF) |
| 5 | Assessment of cardiovascular risk and physical activity: the role of cardiac-specific biomarkers in the general population and athletes | 2.3 | 6 | Citations (PDF) |
| 6 | Direct-to-consumer testing as consumer initiated testing: compromises to the testing process and opportunities for quality improvement | 2.3 | 12 | Citations (PDF) |
| 7 | Vitamin D assay and supplementation: still debatable issues | 1.3 | 6 | Citations (PDF) |
| 8 | Blood self-sampling: friend or foe? | 2.3 | 3 | Citations (PDF) |
| 9 | Clostebol and sport: about controversies involving contamination vs. doping offence | 2.3 | 5 | Citations (PDF) |
| 10 | Performance evaluation of the introduction of full sample traceability system within the specimen collection process | 2.3 | 3 | Citations (PDF) |
| 11 | Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease | 2.3 | 18 | Citations (PDF) |
| 12 | Current trends and future projections in the clinical laboratory test market: implications for resource management and strategic planning | 2.3 | 4 | Citations (PDF) |
| 13 | Non è (più) un paese per laboratoristi | 0.0 | 3 | Citations (PDF) |
| 14 | Measurement of AST and ALT with Pyridoxal-5′-Phosphate according to IFCC: A decades-long gap seems to be filled | 1.5 | 9 | Citations (PDF) |
| 15 | Advancements and challenges in high-sensitivity cardiac troponin assays: diagnostic, pathophysiological, and clinical perspectives | 2.3 | 20 | Citations (PDF) |
| 16 | The journey to pre-analytical quality | 2.3 | 3 | Citations (PDF) |
| 17 | Setting analytical performance specification by simulation (Milan model 1b) | 2.3 | 2 | Citations (PDF) |
| 18 | Lights and shadows of artificial intelligence in laboratory medicine | 0.2 | 9 | Citations (PDF) |
| 19 | Luces y sombras de la inteligencia artificial en la medicina de laboratorio | 0.2 | 0 | Citations (PDF) |
| 20 | The neglected issue of pyridoxal- 5′ phosphate | 2.3 | 1 | Citations (PDF) |
| 21 | Promoting value-based laboratory medicine: Moving towards an innovative model of clinical laboratory | 1.5 | 11 | Citations (PDF) |
| 22 | IFCC recommendations for internal quality control practice: a missed opportunity | 2.3 | 2 | Citations (PDF) |
| 23 | A value-based score for clinical laboratories: promoting the work of the new EFLM committee | 2.3 | 11 | Citations (PDF) |
| 24 | A cost-effective assessment for the combination of indirect immunofluorescence and solid-phase assay in ANA-screening | 2.3 | 2 | Citations (PDF) |
| 25 | Impact of analytical bias on machine learning models for sepsis prediction using laboratory data | 2.3 | 5 | Citations (PDF) |
| 26 | Quality indicators: an evolving target for laboratory medicine | 2.3 | 2 | Citations (PDF) |
| 27 | Can Theranos resurrect from its ashes? | 2.3 | 1 | Citations (PDF) |
| 28 | Rapid rule-in and rule-out protocols of acute myocardial infarction using hs-cTnI and hs-cTnT methods | 2.3 | 15 | Citations (PDF) |
| 29 | Value-based laboratory medicine: the time is now | 2.3 | 16 | Citations (PDF) |
| 30 | Analytical and clinical evaluations of SNIBE Maglumi chemiluminescent immunoassay for the detection of SARS-CoV-2 antigen in salivary samples | 2.3 | 2 | Citations (PDF) |
| 31 | Rising adoption of artificial intelligence in scientific publishing: evaluating the role, risks, and ethical implications in paper drafting and review process | 2.3 | 99 | Citations (PDF) |
| 32 | Machine learning-based nonlinear regression-adjusted real-time quality control modeling: a multi-center study | 2.3 | 13 | Citations (PDF) |
| 33 | Machine learning algorithms in sepsis | 1.5 | 29 | Citations (PDF) |
| 34 | Real-world usage of Chronic Kidney Disease – Mineral Bone Disorder (CKD–MBD) biomarkers in nephrology practices | 3.4 | 19 | Citations (PDF) |
| 35 | Harmonizing the post-analytical phase: focus on the laboratory report | 2.3 | 25 | Citations (PDF) |
| 36 | Clinical and Analytical Performance of ELISA Salivary Serologic Assay to Detect SARS-CoV-2 IgG in Children and Adults | 2.4 | 4 | Citations (PDF) |
| 37 | High-Sensitivity Cardiac Troponin and the Management of Congenital Heart Disease in Newborns and Infants | 1.1 | 6 | Citations (PDF) |
| 38 | Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes | 2.3 | 6 | Citations (PDF) |
| 39 | New reimbursement models to promote better patient outcomes and overall value in laboratory medicine and healthcare | 2.3 | 7 | Citations (PDF) |
| 40 | SARS-CoV-2 is here to stay: do not lower our guard | 2.3 | 2 | Citations (PDF) |
| 41 | Evaluation of the Comparability of Wantai Wan200+ Instrument with Routine Laboratory Assays for 21 Different Analytes | 2.5 | 0 | Citations (PDF) |
| 42 | Hook-effect in MAGLUMI immunoassay for serum anti-GAD antibodies in neurological disorders: When “wrong” matrix is the right choice | 1.5 | 6 | Citations (PDF) |
| 43 | Point-of-care testing, near-patient testing and patient self-testing: warning points | 2.3 | 18 | Citations (PDF) |
| 44 | Utilization management and appropriateness in clinical laboratory: state-of-the-art | 1.5 | 0 | Citations (PDF) |
| 45 | Laboratory medicine and integrated diagnostics: The role of information technology | 1.5 | 1 | Citations (PDF) |
| 46 | A machine learning approach for assessing patients’ disease status by erythrocyte sedimentation rate (ESR) | 1.5 | 0 | Citations (PDF) |
| 47 | A Bayesian statistics approach for quality control and ISO15189 compliance | 1.5 | 0 | Citations (PDF) |
| 48 | Dynamic mirroring: unveiling the role of digital twins, artificial intelligence and synthetic data for personalized medicine in laboratory medicine | 2.3 | 16 | Citations (PDF) |
| 49 | Recent mortality rates due to complications of medical and surgical care in the US | 1.3 | 1 | Citations (PDF) |
| 50 | The growing threat of hijacked journals | 1.3 | 3 | Citations (PDF) |
| 51 | Clinical Chemistry Laboratory Medicine in the post-acute COVID-19 era | 2.3 | 1 | Citations (PDF) |
| 52 | External quality assurance (EQA): navigating between quality and sustainability | 2.3 | 5 | Citations (PDF) |
| 53 | Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity—An Italian Study | 2.5 | 0 | Citations (PDF) |
| 54 | Sex-related differences in vitamin D testing in the Veneto Region, Italy: a retrospective analysis from 2005 to 2016 | 2.5 | 1 | Citations (PDF) |
| 55 | Quality in laboratory medicine and the Journal: walking together | 2.3 | 17 | Citations (PDF) |
| 56 | The new, race-free, Chronic Kidney Disease Epidemiology Consortium (CKD-EPI) equation to estimate glomerular filtration rate: is it applicable in Europe? A position statement by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) | 2.3 | 73 | Citations (PDF) |
| 57 | New insights into SARS-CoV-2 Lumipulse G salivary antigen testing: accuracy, safety and short TAT enhance surveillance | 2.3 | 4 | Citations (PDF) |
| 58 | Seroprevalence of SARS-CoV-2 antibodies in Italy in newborn dried blood spots | 2.3 | 2 | Citations (PDF) |
| 59 | Managing the impact of inter-method bias of prostate specific antigen assays on biopsy referral: the key to move towards precision health in prostate cancer management | 2.3 | 14 | Citations (PDF) |
| 60 | Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands | 2.3 | 24 | Citations (PDF) |
| 61 | An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs) | 2.3 | 14 | Citations (PDF) |
| 62 | Time to address quality control processes applied to antibody testing for infectious diseases | 2.3 | 18 | Citations (PDF) |
| 63 | The harmonization issue in laboratory medicine: the commitment of CCLM | 2.3 | 16 | Citations (PDF) |
| 64 | The gaps between the new EU legislation on in vitro diagnostics and the on-the-ground reality | 2.3 | 10 | Citations (PDF) |
| 65 | Clinical Chemistry and Laboratory Medicine celebrates 60 years – narrative review devoted to the contribution of the journal to the diagnosis of SARS-CoV-2 | 2.3 | 11 | Citations (PDF) |
| 66 | Pre-analytical variability of the Lumipulse immunoassay for plasma biomarkers of Alzheimer’s disease | 2.3 | 20 | Citations (PDF) |
| 67 | Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal | 2.7 | 10 | Citations (PDF) |
| 68 | Diagnostic accuracy of Siemens SARS-CoV-2 Antigen (CoV2Ag) chemiluminescent immunoassay for diagnosing acute SARS-CoV-2 infection: a pooled analysis | 2.3 | 4 | Citations (PDF) |
| 69 | Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays | 2.3 | 4 | Citations (PDF) |
| 70 | A Simple Epidemiologic Model for Predicting Impaired Neutralization of New SARS-CoV-2 Variants | 2.9 | 5 | Citations (PDF) |
| 71 | Deciphering the role of monocyte and monocyte distribution width (MDW) in COVID-19: an updated systematic review and meta-analysis | 2.3 | 16 | Citations (PDF) |
| 72 | Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio | 2.3 | 27 | Citations (PDF) |
| 73 | Quality indicators in laboratory medicine: state-of-the-art, quality specifications and future strategies | 2.3 | 64 | Citations (PDF) |
| 74 | Reference intervals for thyroid biomarkers to enhance the assessment of thyroid status in childhood and adolescence | 2.3 | 8 | Citations (PDF) |
| 75 | Variability of cardiac troponin levels in normal subjects and in patients with cardiovascular diseases: analytical considerations and clinical relevance | 2.3 | 39 | Citations (PDF) |
| 76 | Assessment of humoral and cellular immunity after bivalent BNT162b2 vaccination and potential association with reactogenicity | 2.3 | 7 | Citations (PDF) |
| 77 | Improving access to diagnostic testing in conflict-affected areas: what is needed? | 2.3 | 2 | Citations (PDF) |
| 78 | Why C-reactive protein is one of the most requested tests in clinical laboratories? | 2.3 | 135 | Citations (PDF) |
| 79 | Striving for a pragmatic contribution of biomarkers results to lifelong health care | 2.3 | 2 | Citations (PDF) |
| 80 | Response to Tony Badrick regarding “Letter to the Editor regarding the article by Wayne J. Dimech et al. Time to address quality control processes applied to antibody testing for infectious diseases. Clin Chem Lab Med 2023; 61(2):205–212 by” | 2.3 | 1 | Citations (PDF) |
| 81 | Clinical assessment of SNIBE Maglumi SARS-CoV-2 antigen fully-automated chemiluminescent immunoassay | 2.3 | 3 | Citations (PDF) |
| 82 | Early kinetics of cellular immunity in recipients of bivalent BNT162b2 vaccine: a proof-of-concept study | 2.3 | 1 | Citations (PDF) |
| 83 | SARS-CoV-2 specific T-cell humoral response assessment after COVID-19 vaccination using a rapid direct real-time PCR amplification | 2.3 | 5 | Citations (PDF) |
| 84 | Addressing standardized definitions of post-COVID and long-COVID | 2.3 | 15 | Citations (PDF) |
| 85 | ChatGPT: Angel or Demond? Critical thinking is still needed | 2.3 | 19 | Citations (PDF) |
| 86 | Analytical evaluation of a GAD65 antibodies chemiluminescence immunoassay for CSF in neurological syndromes | 2.3 | 3 | Citations (PDF) |
| 87 | Artificial intelligence and laboratory data in rheumatic diseases | 1.5 | 11 | Citations (PDF) |
| 88 | Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE) | 2.3 | 4 | Citations (PDF) |
| 89 | Adherence to recommendations and clinical practice guidelines: not an easy task | 2.3 | 5 | Citations (PDF) |
| 90 | Measurement of Cardiac-Specific Biomarkers in the Emergency Department: New Insight in Risk Evaluation | 4.4 | 8 | Citations (PDF) |
| 91 | Left ventricular longitudinal strain alterations in asymptomatic or mildly symptomatic paediatric patients with SARS-CoV-2 infection | 1.4 | 24 | Citations (PDF) |
| 92 | The European Biological Variation Study (EuBIVAS): a summary report | 2.3 | 74 | Citations (PDF) |
| 93 | Theranos revisited: the trial and lessons learned | 2.3 | 10 | Citations (PDF) |
| 94 | Diabetes mellitus and Parkinson’s disease: dangerous liaisons between insulin and dopamine | 5.3 | 40 | Citations (PDF) |
| 95 | Competent Well-Trained Phlebotomists | 0.7 | 0 | Citations (PDF) |
| 96 | Alemtuzumab‐induced autoimmune thyroid events in patients with relapsing‐remitting multiple sclerosis: A real‐life and monocentric experience at a tertiary‐level centre | 2.3 | 7 | Citations (PDF) |
| 97 | Extrapolated normative GFR data for living kidney donation | 2.3 | 0 | Citations (PDF) |
| 98 | A rapid semi-quantitative test for determination of SARS-CoV-2 antibody levels | 2.3 | 3 | Citations (PDF) |
| 99 | The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization | 2.1 | 3 | Citations (PDF) |
| 100 | Hyris bCUBE SARS-CoV-2 rapid molecular saliva testing: a POCT innovation on its way | 2.3 | 5 | Citations (PDF) |
| 101 | Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine? | 1.8 | 29 | Citations (PDF) |
| 102 | Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19 | 4.2 | 10 | Citations (PDF) |
| 103 | Virucidal effects of mouthwashes or mouth rinses: a world of caution for molecular detection of SARS-CoV-2 in saliva | 1.3 | 5 | Citations (PDF) |
| 104 | Protective SARS-CoV-2 Antibody Response in Children With Inflammatory Bowel Disease | 1.7 | 4 | Citations (PDF) |
| 105 | The Role of Vitamin K in CKD-MBD | 4.6 | 11 | Citations (PDF) |
| 106 | Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants | 2.3 | 37 | Citations (PDF) |
| 107 | Lot-to-lot variation: no longer a neglected issue | 2.3 | 13 | Citations (PDF) |
| 108 | The University of Padua salivary-based SARS-CoV-2 surveillance program minimized viral transmission during the second and third pandemic wave | 7.1 | 7 | Citations (PDF) |
| 109 | Health Technology Assessment to assess value of biomarkers in the decision-making process | 2.3 | 25 | Citations (PDF) |
| 110 | Preanalytical quality improvement – an interdisciplinary journey | 2.3 | 19 | Citations (PDF) |
| 111 | Interferences in immunoassays: review and practical algorithm | 2.3 | 103 | Citations (PDF) |
| 112 | Diagnostic accuracy of the ultrasensitive S-PLEX SARS-CoV-2 N electrochemiluminescence immunoassay | 2.3 | 12 | Citations (PDF) |
| 113 | Fujirebio Lumipulse SARS-CoV-2 antigen immunoassay: pooled analysis of diagnostic accuracy | 1.3 | 16 | Citations (PDF) |
| 114 | Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies | 7.3 | 74 | Citations (PDF) |
| 115 | Two rapid SARS-CoV-2 disposable devices for semi-quantitative S-RBD antibody levels determination compared with CLIA and ELISA assays at different protective thresholds | 1.5 | 1 | Citations (PDF) |
| 116 | Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays | 2.3 | 37 | Citations (PDF) |
| 117 | A highly accurate delta check method using deep learning for detection of sample mix-up in the clinical laboratory | 2.3 | 23 | Citations (PDF) |
| 118 | High sensitive cardiac troponin: biological variation, circadian rhythm and diagnostic algorithms | 1.3 | 0 | Citations (PDF) |
| 119 | T Cell Senescence by Extensive Phenotyping: An Emerging Feature of COVID-19 Severity | 1.0 | 4 | Citations (PDF) |
| 120 | LumiraDX SARS-CoV-2 Antigen Test for Diagnosing Acute SARS-CoV-2 Infection: Critical Literature Review and Meta-Analysis | 2.8 | 7 | Citations (PDF) |
| 121 | Longitudinal analysis of T cell receptor repertoires reveals shared patterns of antigen-specific response to SARS-CoV-2 infection | 5.4 | 54 | Citations (PDF) |
| 122 | Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group | 2.3 | 15 | Citations (PDF) |
| 123 | A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers | 2.3 | 18 | Citations (PDF) |
| 124 | Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism | 4.4 | 22 | Citations (PDF) |
| 125 | The never-ending quest for antibody assays standardization and appropriate measurement units | 2.3 | 2 | Citations (PDF) |
| 126 | TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism | 2.3 | 6 | Citations (PDF) |
| 127 | Transdermal measurement of cardiac troponins: the future is now | 2.3 | 4 | Citations (PDF) |
| 128 | The VES-Matic 5 system: performance of a novel instrument for measuring erythrocyte sedimentation rate | 2.3 | 10 | Citations (PDF) |
| 129 | Perinatal presepsin assessment: a new sepsis diagnostic tool? | 2.3 | 16 | Citations (PDF) |
| 130 | Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease | 4.4 | 108 | Citations (PDF) |
| 131 | The relevance of establishing method-dependent decision thresholds of serum folate in pregnancy and lactation: when the laboratory stewardship meets the health-care needs | 2.3 | 7 | Citations (PDF) |
| 132 | Rethinking internal quality control: the time is now | 2.3 | 15 | Citations (PDF) |
| 133 | Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future | 2.3 | 6 | Citations (PDF) |
| 134 | Traceable machine learning real-time quality control based on patient data | 2.3 | 30 | Citations (PDF) |
| 135 | Flowing through laboratory clinical data: the role of artificial intelligence and big data | 2.3 | 36 | Citations (PDF) |
| 136 | Biohumoral Predictors of Advanced Pancreatic Carcinoma Not Shown at Pre-operative Imaging | 0.2 | 0 | Citations (PDF) |
| 137 | Long-term Immune Response to SARS-CoV-2 Infection Among Children and Adults After Mild Infection | 6.6 | 63 | Citations (PDF) |
| 138 | A multi-model fusion algorithm as a real-time quality control tool for small shift detection | 6.3 | 12 | Citations (PDF) |
| 139 | Evaluation of the cardiovascular risk in patients undergoing major non-cardiac surgery: role of cardiac-specific biomarkers | 2.3 | 17 | Citations (PDF) |
| 140 | What is the impact of circulating histones in COVID-19: a systematic review | 2.3 | 13 | Citations (PDF) |
| 141 | Control interno de la calidad y garantía externa de la calidad: un gran pasado abre el camino a un brillante futuro | 0.2 | 0 | Citations (PDF) |
| 142 | Fibroblast growth factor 23: translating analytical improvement into clinical effectiveness for tertiary prevention in chronic kidney disease | 2.3 | 6 | Citations (PDF) |
| 143 | Internal quality control and external quality assurance: a great past opens the way to a bright future | 0.2 | 4 | Citations (PDF) |
| 144 | Artificial intelligence: is it the right time for clinical laboratories? | 2.3 | 17 | Citations (PDF) |
| 145 | Lot-to-lot variation: no longer a neglected issue | 0.2 | 0 | Citations (PDF) |
| 146 | A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis | 2.5 | 10 | Citations (PDF) |
| 147 | Tube shaking and pneumatic transportation: impact on presepsin concentrations measured by both fully automated and POCT analyzers | 2.3 | 0 | Citations (PDF) |
| 148 | Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial | 0.8 | 7 | Citations (PDF) |
| 149 | High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension | 5.5 | 52 | Citations (PDF) |
| 150 | Serum uric acid levels and the risk of recurrent venous thromboembolism | 3.8 | 29 | Citations (PDF) |
| 151 | Performance of the COVID19SEROSpeed IgM/IgG Rapid Test, an Immunochromatographic Assay for the Diagnosis of SARS-CoV-2 Infection: a Multicenter European Study | 4.0 | 11 | Citations (PDF) |
| 152 | Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study | 4.9 | 23 | Citations (PDF) |
| 153 | Sperm Count and Hypogonadism as Markers of General Male Health | 3.5 | 93 | Citations (PDF) |
| 154 | Phosphate and bone fracture risk in chronic kidney disease patients | 0.8 | 24 | Citations (PDF) |
| 155 | Vitamin K in CKD Bone Disorders | 2.8 | 20 | Citations (PDF) |
| 156 | A challenging liver transplantation for decompensated alcoholic liver disease after recovery from SARS‐CoV‐2 infection | 2.0 | 6 | Citations (PDF) |
| 157 | The role of procalcitonin in reducing antibiotics across the surgical pathway | 4.9 | 9 | Citations (PDF) |
| 158 | Machine learning‐based analysis of alveolar and vascular injury in SARS‐CoV‐2 acute respiratory failure | 4.9 | 31 | Citations (PDF) |
| 159 | Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma | 3.8 | 18 | Citations (PDF) |
| 160 | Monocyte distribution width (MDW) parameter as a sepsis indicator in intensive care units | 2.3 | 61 | Citations (PDF) |
| 161 | Laboratory medicine in the COVID-19 era: six lessons for the future | 2.3 | 24 | Citations (PDF) |
| 162 | Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience | 1.8 | 22 | Citations (PDF) |
| 163 | Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers | 2.3 | 56 | Citations (PDF) |
| 164 | IgM anti-SARS-CoV-2-specific determination: useful or confusing? Big Data analysis of a real-life scenario | 2.6 | 12 | Citations (PDF) |
| 165 | A Novel Circulating Noncoding Small RNA for the Detection of Acute Myocarditis | 34.5 | 182 | Citations (PDF) |
| 166 | It’s not just the lungs: COVID-19 and the misty mesentery sign | 1.4 | 8 | Citations (PDF) |
| 167 | Harmonization status of procalcitonin measurements: what do comparison studies and EQA schemes tell us? | 2.3 | 23 | Citations (PDF) |
| 168 | Neonatal lymphocyte subpopulations analysis and maternal preterm premature rupture of membranes: a pilot study | 2.3 | 6 | Citations (PDF) |
| 169 | Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers | 4.5 | 53 | Citations (PDF) |
| 170 | SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology | 4.9 | 4 | Citations (PDF) |
| 171 | High-sensitivity assay for cardiac troponins with POCT methods. The future is soon | 2.3 | 24 | Citations (PDF) |
| 172 | Defining laboratory medicine: a circle cannot be squared | 1.1 | 0 | Citations (PDF) |
| 173 | Serum Anti-Heart and Anti-Intercalated Disk Autoantibodies: Novel Autoimmune Markers in Cardiac Sarcoidosis | 2.5 | 18 | Citations (PDF) |
| 174 | SARS-CoV-2 antibody assay after vaccination: one size does not fit all | 2.3 | 6 | Citations (PDF) |
| 175 | Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study | 1.5 | 62 | Citations (PDF) |
| 176 | SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ | 13.7 | 40 | Citations (PDF) |
| 177 | Drone transport of biological samples: an open issue | 2.3 | 6 | Citations (PDF) |
| 178 | Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease | 4.2 | 5 | Citations (PDF) |
| 179 | Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets’ attainment in subjects with and without type 2 diabetes | 9.4 | 25 | Citations (PDF) |
| 180 | Diagnostic algorithms for non-ST-segment elevation myocardial infarction: open issues | 2.3 | 3 | Citations (PDF) |
| 181 | Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study | 3.4 | 15 | Citations (PDF) |
| 182 | Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme | 2.3 | 8 | Citations (PDF) |
| 183 | Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers | 1.5 | 76 | Citations (PDF) |
| 184 | Novel Criteria for the Observe-Zone of the ESC 0/1h-hs-cTnT Algorithm | 18.0 | 50 | Citations (PDF) |
| 185 | Endothelial dysfunction and Mid-Regional proAdrenomedullin: What role in SARS-CoV-2 infected Patients? | 1.5 | 16 | Citations (PDF) |
| 186 | Rapid changes of miRNAs-20, -30, −410, −515, −134, and −183 and telomerase with psychological activity: A one year study on the relaxation response and epistemological considerations | 2.9 | 11 | Citations (PDF) |
| 187 | Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine | 2.3 | 55 | Citations (PDF) |
| 188 | Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role? | 2.3 | 19 | Citations (PDF) |
| 189 | Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study | 4.4 | 65 | Citations (PDF) |
| 190 | Automated Mindray CL-1200i chemiluminescent assays of renin and aldosterone for the diagnosis of primary aldosteronism | 2.3 | 2 | Citations (PDF) |
| 191 | Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination | 2.3 | 24 | Citations (PDF) |
| 192 | Distance from the outbreak of infection, ozone pollution and public health consequences of SARS-CoV-2 epidemic: the HOPE method | 0.3 | 9 | Citations (PDF) |
| 193 | Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patients | 2.3 | 11 | Citations (PDF) |
| 194 | Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers | 2.3 | 55 | Citations (PDF) |
| 195 | High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy | 2.3 | 14 | Citations (PDF) |
| 196 | Influence of patients’ clinical features at intensive care unit admission on performance of cell cycle arrest biomarkers in predicting acute kidney injury | 2.3 | 3 | Citations (PDF) |
| 197 | Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection | 2.3 | 22 | Citations (PDF) |
| 198 | Clinical relevance of biological variation of cardiac troponins | 2.3 | 53 | Citations (PDF) |
| 199 | Cytokine “storm”, cytokine “breeze”, or both in COVID-19? | 2.3 | 26 | Citations (PDF) |
| 200 | Home pregnancy tests: quality first | 2.3 | 1 | Citations (PDF) |
| 201 | Between Web search engines and artificial intelligence: what side is shown in laboratory tests? | 1.3 | 5 | Citations (PDF) |
| 202 | Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows | 3.8 | 22 | Citations (PDF) |
| 203 | The Vessels-Bone Axis: Iliac Artery Calcifications, Vertebral Fractures and Vitamin K from VIKI Study | 4.4 | 9 | Citations (PDF) |
| 204 | Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study | 4.9 | 13 | Citations (PDF) |
| 205 | Comparison of Cortisol, Androstenedione and Metanephrines to Assess Selectivity and Lateralization of Adrenal Vein Sampling in Primary Aldosteronism | 2.5 | 25 | Citations (PDF) |
| 206 | Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1–3 | 2.3 | 2 | Citations (PDF) |
| 207 | Cardiotoxic effects and myocardial injury: the search for a more precise definition of drug cardiotoxicity | 2.3 | 22 | Citations (PDF) |
| 208 | SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays | 1.5 | 22 | Citations (PDF) |
| 209 | The Italian External Quality Assessment (EQA) program on urinary sediment by microscopy examination: a 20 years journey | 2.3 | 2 | Citations (PDF) |
| 210 | Chest pain management and biomarkers: the lack of trust in cardiac troponins measurement | 1.3 | 0 | Citations (PDF) |
| 211 | Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates | 2.8 | 22 | Citations (PDF) |
| 212 | Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine | 2.9 | 30 | Citations (PDF) |
| 213 | Can ultrasensitive thyroglobulin immunoassays avoid the need for ultrasound in thyroid cancer follow-up? | 2.5 | 3 | Citations (PDF) |
| 214 | Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy | 2.3 | 15 | Citations (PDF) |
| 215 | Serum or plasma? An old question looking for new answers | 2.3 | 56 | Citations (PDF) |
| 216 | Erythrocyte Sedimentation Rate and C-Reactive Protein in Acute Inflammation | 0.7 | 146 | Citations (PDF) |
| 217 | Total testing process: roots and state-of-the-art | 1.3 | 7 | Citations (PDF) |
| 218 | Evaluation of an improved small gauge needle for venipuncture in children with difficult venous access: Impact on sample quality, phlebotomist satisfaction and patient pain perception | 1.5 | 8 | Citations (PDF) |
| 219 | Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure | 6.0 | 54 | Citations (PDF) |
| 220 | Understanding and managing interferences in clinical laboratory assays: the role of laboratory professionals | 2.3 | 21 | Citations (PDF) |
| 221 | Analytical validation of the iSED automated analyzer for erythrocyte sedimentation rate | 1.4 | 9 | Citations (PDF) |
| 222 | Emerging role of monocytes and their intracellular calcium pattern in spondyloarthritis | 1.5 | 8 | Citations (PDF) |
| 223 | Performance evaluation of 14 specific proteins measurement checked by an External Quality Assessment Scheme | 1.5 | 4 | Citations (PDF) |
| 224 | Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements | 1.5 | 2 | Citations (PDF) |
| 225 | P1645VITAMIN K DEPENDENT PROTEINS AFTER KIDNEY TRANSPLANTATION: RESULTS FROM PROSPECTIVE STUDY | 0.8 | 0 | Citations (PDF) |
| 226 | Endocrine disruption of vitamin D activity by perfluoro-octanoic acid (PFOA) | 3.4 | 70 | Citations (PDF) |
| 227 | Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring | 1.5 | 21 | Citations (PDF) |
| 228 | Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells | 4.2 | 12 | Citations (PDF) |
| 229 | Vitamin K and Osteoporosis | 4.4 | 112 | Citations (PDF) |
| 230 | Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity | 9.7 | 142 | Citations (PDF) |
| 231 | Universal screening of high-risk neonates, parents, and staff at a neonatal intensive care unit during the SARS-CoV-2 pandemic | 2.1 | 23 | Citations (PDF) |
| 232 | Recognition of the Prehospital Preanalytical Phase: Collaborative Efforts between Laboratory Medicine and Emergency Medicine to Ensure Quality Testing | 1.1 | 9 | Citations (PDF) |
| 233 | Harmonization of two hs-cTnI methods based on recalibration of measured quality control and clinical samples | 1.5 | 18 | Citations (PDF) |
| 234 | SARS-CoV-2 identification and IgA antibodies in saliva: One sample two tests approach for diagnosis | 1.5 | 65 | Citations (PDF) |
| 235 | Toward a Unified View of Cognitive and Biochemical Activity: Meditation and Linguistic Self-Reconstructing May Lead to Inflammation and Oxidative Stress Improvement | 1.7 | 13 | Citations (PDF) |
| 236 | Vitamin K and Kidney Transplantation | 4.4 | 9 | Citations (PDF) |
| 237 | Validation of a composed COVID-19 chest radiography score: the CARE project | 2.5 | 19 | Citations (PDF) |
| 238 | Commutability of external quality assessment materials for point‐of‐care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches | 2.7 | 12 | Citations (PDF) |
| 239 | Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays? | 1.5 | 104 | Citations (PDF) |
| 240 | Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review | 1.8 | 139 | Citations (PDF) |
| 241 | Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis | 1.6 | 492 | Citations (PDF) |
| 242 | Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis | 2.6 | 13 | Citations (PDF) |
| 243 | Laboratory abnormalities in children with novel coronavirus disease 2019 | 2.3 | 209 | Citations (PDF) |
| 244 | Measurement uncertainty: light in the shadows | 2.3 | 8 | Citations (PDF) |
| 245 | Laboratory abnormalities in patients with COVID-2019 infection | 2.3 | 805 | Citations (PDF) |
| 246 | The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks | 2.3 | 316 | Citations (PDF) |
| 247 | Reticulated platelets and immature platelet fraction: Clinical applications and method limitations | 1.4 | 59 | Citations (PDF) |
| 248 | Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis | 1.5 | 1,468 | Citations (PDF) |
| 249 | Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) | 2.3 | 531 | Citations (PDF) |
| 250 | Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy | 18.0 | 102 | Citations (PDF) |
| 251 | Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma | 1.5 | 24 | Citations (PDF) |
| 252 | Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects | 1.5 | 41 | Citations (PDF) |
| 253 | New insights on the analytical performances for detecting and quantifying monoclonal proteins | 2.3 | 3 | Citations (PDF) |
| 254 | Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay | 2.8 | 9 | Citations (PDF) |
| 255 | Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation | 2.8 | 70 | Citations (PDF) |
| 256 | The novel coronavirus (2019-nCoV) outbreak: think the unthinkable and be prepared to face the challenge | 1.3 | 55 | Citations (PDF) |
| 257 | IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study | 1.5 | 303 | Citations (PDF) |
| 258 | Possible clinical role of MOG antibody testing in children presenting with acute neurological symptoms | 1.7 | 2 | Citations (PDF) |
| 259 | Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype | 4.9 | 17 | Citations (PDF) |
| 260 | Presepsin in risk stratification of SARS-CoV-2 patients | 1.5 | 68 | Citations (PDF) |
| 261 | Integrated diagnostics | 1.1 | 52 | Citations (PDF) |
| 262 | Laboratory medicine resilience during coronavirus disease 2019 (COVID-19) pandemic | 0.2 | 10 | Citations (PDF) |
| 263 | Peptidomic and proteomic analysis of stool for diagnosing IBD and deciphering disease pathogenesis | 2.3 | 18 | Citations (PDF) |
| 264 | Percentile transformation and recalibration functions allow harmonization of thyroid-stimulating hormone (TSH) immunoassay results | 2.3 | 18 | Citations (PDF) |
| 265 | A modern and pragmatic definition of Laboratory Medicine | 2.3 | 47 | Citations (PDF) |
| 266 | Quality controls for serology: an unfinished agenda | 2.3 | 7 | Citations (PDF) |
| 267 | One disease, different features: COVID-19 laboratory and radiological findings in three Italian patients | 2.3 | 11 | Citations (PDF) |
| 268 | Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis | 2.3 | 1,642 | Citations (PDF) |
| 269 | Clinical laboratory and SARS-CoV-2 infection: where do we stand? | 2.3 | 11 | Citations (PDF) |
| 270 | Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics | 2.3 | 276 | Citations (PDF) |
| 271 | Erythrocyte sedimentation rate is associated with severe coronavirus disease 2019 (COVID-19): a pooled analysis | 2.3 | 47 | Citations (PDF) |
| 272 | SARS-CoV-2 RNA identification in nasopharyngeal swabs: issues in pre-analytics | 2.3 | 57 | Citations (PDF) |
| 273 | Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice | 2.3 | 16 | Citations (PDF) |
| 274 | “Stay home stay safe?” Systemic inflammation in subjects undergoing routine hematology tests during the lockdown period of COVID-19 | 2.3 | 5 | Citations (PDF) |
| 275 | Evaluation of an ELISA for SARS-CoV-2 antibody testing: clinical performances and correlation with plaque reduction neutralization titer | 2.3 | 13 | Citations (PDF) |
| 276 | SARS-CoV-2 serosurvey in health care workers of the Veneto Region | 2.3 | 68 | Citations (PDF) |
| 277 | SARS-CoV-2 antibody performances: we need better criteria | 2.3 | 5 | Citations (PDF) |
| 278 | Asymptomatic COVID-19 transmission: the importance of avoiding official miscommunication | 1.3 | 9 | Citations (PDF) |
| 279 | A modern and pragmatic definition of Laboratory Medicine | 0.2 | 1 | Citations (PDF) |
| 280 | La capacidad de resiliencia de la medicina de laboratorio durante la pandemia de la enfermedad por coronavirus (COVID-19) iniciada en 2019 | 0.2 | 0 | Citations (PDF) |
| 281 | Molecular diagnostics at the times of SARS-CoV-2 outbreak | 1.3 | 3 | Citations (PDF) |
| 282 | Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset | 3.9 | 31 | Citations (PDF) |
| 283 | The Model List of Essential In Vitro Diagnostics: nuisance or opportunity? | 1.3 | 6 | Citations (PDF) |
| 284 | Blood biomarkers in neurology: “a call to arms” for laboratory professionals | 2.3 | 8 | Citations (PDF) |
| 285 | CCLM Award for the Most Cited Paper | 2.3 | 1 | Citations (PDF) |
| 286 | Free light chains in cerebrospinal fluid of multiple sclerosis patients negative for IgG oligoclonal bands | 1.5 | 15 | Citations (PDF) |
| 287 | Reflex TSH strategy: the good, the bad and the ugly | 2.3 | 21 | Citations (PDF) |
| 288 | Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) | 4.9 | 13 | Citations (PDF) |
| 289 | Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: A multi-center study | 1.5 | 58 | Citations (PDF) |
| 290 | Interference of lipemia in samples for routine coagulation testing using a Sysmex CS‐5100 coagulometer | 1.4 | 12 | Citations (PDF) |
| 291 | The Effects of Iodine Supplementation in Pregnancy on Iodine Status, Thyroglobulin Levels and Thyroid Function Parameters: Results from a Randomized Controlled Clinical Trial in a Mild-to-Moderate Iodine Deficiency Area | 4.4 | 43 | Citations (PDF) |
| 292 | Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays | 2.3 | 34 | Citations (PDF) |
| 293 | Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy | 2.3 | 2 | Citations (PDF) |
| 294 | Extra-analytical sources of uncertainty: which ones really matter? | 2.3 | 12 | Citations (PDF) |
| 295 | Identification and management of spurious hemolysis: controversies, concerns and criticisms | 2.3 | 4 | Citations (PDF) |
| 296 | Preanalytical challenges – time for solutions | 2.3 | 61 | Citations (PDF) |
| 297 | Professor Howard A. Morris | 2.3 | 0 | Citations (PDF) |
| 298 | Decision Support and Patient Safety | 1.1 | 19 | Citations (PDF) |
| 299 | Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study | 2.3 | 86 | Citations (PDF) |
| 300 | C-peptide and insulin assays with the Mindray CL-2000i: Precision and comparability with different methods | 1.5 | 5 | Citations (PDF) |
| 301 | The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples | 1.7 | 5 | Citations (PDF) |
| 302 | Activation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patients | 2.5 | 26 | Citations (PDF) |
| 303 | The silk road to total quality in Laboratory Medicine | 2.3 | 6 | Citations (PDF) |
| 304 | Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case–control study | 1.9 | 19 | Citations (PDF) |
| 305 | Automated measurement of the erythrocyte sedimentation rate: method validation and comparison | 2.3 | 36 | Citations (PDF) |
| 306 | Cost, profitability and value of laboratory diagnostics: in God we trust, all others bring data | 1.1 | 18 | Citations (PDF) |
| 307 | Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use | 2.3 | 238 | Citations (PDF) |
| 308 | Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity | 4.4 | 336 | Citations (PDF) |
| 309 | Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease | 2.3 | 9 | Citations (PDF) |
| 310 | Symptoms Predictive of Acute Myocardial Infarction in the Troponin Era: Analysis From the TRAPID-AMI Study | 0.2 | 10 | Citations (PDF) |
| 311 | Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus | 1.5 | 17 | Citations (PDF) |
| 312 | The circulating miRNAs as diagnostic and prognostic markers | 2.3 | 55 | Citations (PDF) |
| 313 | Endocrine Disruption of Androgenic Activity by Perfluoroalkyl Substances: Clinical and Experimental Evidence | 4.0 | 144 | Citations (PDF) |
| 314 | A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: preliminary findings in China | 2.3 | 2 | Citations (PDF) |
| 315 | Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction | 2.2 | 32 | Citations (PDF) |
| 316 | Diabetes alert dogs: a narrative critical overview | 2.3 | 18 | Citations (PDF) |
| 317 | What information on measurement uncertainty should be communicated to clinicians, and how? | 0.2 | 0 | Citations (PDF) |
| 318 | Antioxidant capacity in patients with type 2 diabetes: a preliminary investigation on gender-specific differences in an Italian population | 2.3 | 2 | Citations (PDF) |
| 319 | Clinical usefulness of Glycated Albumin in the diagnosis of diabetes: Results from an Italian study | 1.8 | 44 | Citations (PDF) |
| 320 | Clinical relevance and future perspective of fractures in patients with chronic kidney disease | 5.3 | 1 | Citations (PDF) |
| 321 | Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial | 2.0 | 3 | Citations (PDF) |
| 322 | Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction | 2.3 | 25 | Citations (PDF) |
| 323 | Quality and future of clinical laboratories: the Vico’s whole cyclical theory of the recurring cycles | 2.3 | 41 | Citations (PDF) |
| 324 | What information on measurement uncertainty should be communicated to clinicians, and how? | 1.8 | 31 | Citations (PDF) |
| 325 | How is cardiac troponin released from injured myocardium? | 1.0 | 224 | Citations (PDF) |
| 326 | Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers | 1.5 | 29 | Citations (PDF) |
| 327 | Extra-analytical quality indicators – where to now? | 2.3 | 16 | Citations (PDF) |
| 328 | Scientific publishing in the “predatory” era | 2.3 | 8 | Citations (PDF) |
| 329 | HCV core antigen comes of age: a new opportunity for the diagnosis of hepatitis C virus infection | 2.3 | 28 | Citations (PDF) |
| 330 | miRNAs may change rapidly with thoughts: The Relaxation Response after myocardial infarction | 1.4 | 13 | Citations (PDF) |
| 331 | Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results | 1.8 | 27 | Citations (PDF) |
| 332 | What to do when you question cardiac troponin values | 1.0 | 81 | Citations (PDF) |
| 333 | Laboratory testing in the emergency department: an Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) and Academy of Emergency Medicine and Care (AcEMC) consensus report | 2.3 | 17 | Citations (PDF) |
| 334 | Thoughts modulate the expression of inflammatory genes and may improve the coronary blood flow in patients after a myocardial infarction | 2.9 | 24 | Citations (PDF) |
| 335 | Use of copeptin for rapid rule-out of acute myocardial infarction | 1.0 | 58 | Citations (PDF) |
| 336 | Copeptin as a diagnostic and prognostic biomarker in patients admitted to Emergency Department with syncope, presyncope and vertiginous syndrome | 2.3 | 3 | Citations (PDF) |
| 337 | Analytical quality: an unfinished journey | 2.3 | 17 | Citations (PDF) |
| 338 | Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature | 2.3 | 28 | Citations (PDF) |
| 339 | Effect of preanalytical and analytical variables on the clinical utility of mean platelet volume | 2.3 | 17 | Citations (PDF) |
| 340 | Harmonization in laboratory medicine: more than clinical chemistry? | 2.3 | 47 | Citations (PDF) |
| 341 | Harmonization in laboratory medicine: Blowin’ in the wind | 2.3 | 9 | Citations (PDF) |
| 342 | Jillian Russyll (AKA Jill) Tate | 2.3 | 0 | Citations (PDF) |
| 343 | The International Society for Enzymology: a glorious history, a golden legacy | 2.3 | 0 | Citations (PDF) |
| 344 | Influence of serum 25-hydroxyvitamin D levels, fat-free mass, and fat mass on bone density, geometry and strength, in healthy young and elderly adults | 3.7 | 3 | Citations (PDF) |
| 345 | The Theranos saga and the consequences | 2.3 | 10 | Citations (PDF) |
| 346 | System-related and cognitive errors in laboratory medicine | 1.3 | 11 | Citations (PDF) |
| 347 | PSA-based, prostate cancer risk on-line calculators: no such thing as a crystal ball? | 1.3 | 0 | Citations (PDF) |
| 348 | Diagnostic test accuracy: a valuable tool for promoting quality and patient safety | 1.3 | 2 | Citations (PDF) |
| 349 | FP601DECREASED OSTEOCALCIN LEVELS AND INCREASED MORTALITY IN HEMODIALYSIS PATIENTS WITH DIABETES MELLITUS | 0.8 | 0 | Citations (PDF) |
| 350 | Analytical performance evaluation of the new GEM® Premier™ 5000 analyzer in comparison to the GEM® Premier™ 4000 and the RapidPoint® 405 systems | 1.5 | 17 | Citations (PDF) |
| 351 | Impact of age on the performance of the ESC 0/1h-algorithms for early diagnosis of myocardial infarction | 2.2 | 112 | Citations (PDF) |
| 352 | RANKL Expression Is Increased in Circulating Mononuclear Cells of Patients with Calcific Aortic Stenosis | 2.0 | 10 | Citations (PDF) |
| 353 | External quality assessment programs in the context of ISO 15189 accreditation | 2.3 | 51 | Citations (PDF) |
| 354 | Warfarin, but not rivaroxaban, promotes the calcification of the aortic valve in ApoE−/− mice | 5.3 | 38 | Citations (PDF) |
| 355 | Diagnosis is now indexed in PubMed | 1.3 | 2 | Citations (PDF) |
| 356 | Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation | 1.5 | 20 | Citations (PDF) |
| 357 | The EuBIVAS: Within- and Between-Subject Biological Variation Data for Electrolytes, Lipids, Urea, Uric Acid, Total Protein, Total Bilirubin, Direct Bilirubin, and Glucose | 1.1 | 97 | Citations (PDF) |
| 358 | MALDI-TOF peptidomic analysis of serum and post-prostatic massage urine specimens to identify prostate cancer biomarkers | 2.8 | 12 | Citations (PDF) |
| 359 | Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine | 2.3 | 0 | Citations (PDF) |
| 360 | Metyrapone treatment in Cushing’s syndrome: a real-life study | 2.5 | 67 | Citations (PDF) |
| 361 | Norbert Tietz, 13th November 1926–23rd May 2018 | 2.3 | 0 | Citations (PDF) |
| 362 | Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination | 1.5 | 11 | Citations (PDF) |
| 363 | Improving IBD diagnosis and monitoring by understanding preanalytical, analytical and biological fecal calprotectin variability | 2.3 | 40 | Citations (PDF) |
| 364 | Harmonization of units and reference intervals of plasma proteins: state of the art from an External Quality Assessment Scheme | 2.3 | 6 | Citations (PDF) |
| 365 | Procalcitonin-guided antibiotic therapy: an expert consensus | 2.3 | 62 | Citations (PDF) |
| 366 | Clinical laboratory: bigger is not always better | 1.3 | 36 | Citations (PDF) |
| 367 | Reply to the letter “Could cardiac troponin I levels predict mortality in the elderly?” | 2.7 | 0 | Citations (PDF) |
| 368 | Prognostic value of cardiac troponin I assay in hospitalized elderly patients | 2.7 | 7 | Citations (PDF) |
| 369 | Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy | 2.3 | 19 | Citations (PDF) |
| 370 | Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? | 1.0 | 24 | Citations (PDF) |
| 371 | How to use D-dimer in acute cardiovascular care | 1.0 | 64 | Citations (PDF) |
| 372 | The principles of Health Technology Assessment in laboratory medicine | 2.3 | 15 | Citations (PDF) |
| 373 | Editor’s Choice-Rule-in of acute myocardial infarction: Focus on troponin | 1.0 | 36 | Citations (PDF) |
| 374 | Low vitamin K1 intake in haemodialysis patients | 5.3 | 46 | Citations (PDF) |
| 375 | Rapid rule out of acute myocardial infarction: novel biomarker-based strategies | 1.0 | 79 | Citations (PDF) |
| 376 | Performance specifications for the extra-analytical phases of laboratory testing: Why and how | 1.8 | 29 | Citations (PDF) |
| 377 | DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes | 9.4 | 16 | Citations (PDF) |
| 378 | Reporting altered test results in hemolyzed samples: is the cure worse than the disease? | 2.3 | 19 | Citations (PDF) |
| 379 | First-line screening tests for Cushing’s syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS | 2.8 | 42 | Citations (PDF) |
| 380 | Biotin interference on immunoassay methods: sporadic cases or hidden epidemic? | 2.3 | 25 | Citations (PDF) |
| 381 | Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Diagnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation | 1.1 | 36 | Citations (PDF) |
| 382 | Innovative software for recording preanalytical errors in accord with the IFCC quality indicators | 2.3 | 29 | Citations (PDF) |
| 383 | Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department | 4.1 | 80 | Citations (PDF) |
| 384 | Parathormone stability in hemodialyzed patients and healthy subjects: comparison on non-centrifuged EDTA and serum samples with second- and third-generation assays | 2.3 | 14 | Citations (PDF) |
| 385 | An approach for estimating measurement uncertainty in medical laboratories using data from long-term quality control and external quality assessment schemes | 2.3 | 38 | Citations (PDF) |
| 386 | Biological Variation Estimates Obtained from 91 Healthy Study Participants for 9 Enzymes in Serum | 1.1 | 60 | Citations (PDF) |
| 387 | Performance specifications in extra-analytical phase of laboratory testing: Sample handling and transportation | 1.8 | 13 | Citations (PDF) |
| 388 | ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate | 1.4 | 86 | Citations (PDF) |
| 389 | Impaired Release of Vitamin D in Dysfunctional Adipose Tissue: New Cues on Vitamin D Supplementation in Obesity | 4.0 | 53 | Citations (PDF) |
| 390 | The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications | 2.3 | 78 | Citations (PDF) |
| 391 | Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH‐dependent Cushing's syndrome | 2.3 | 28 | Citations (PDF) |
| 392 | Quantitative Value of Aldosterone‐Renin Ratio for Detection of Aldosterone‐Producing Adenoma: The Aldosterone‐Renin Ratio for Primary Aldosteronism (AQUARR) Study | 4.0 | 83 | Citations (PDF) |
| 393 | Biomarkers of acute kidney injury: a step forward | 2.3 | 4 | Citations (PDF) |
| 394 | High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study | 1.9 | 9 | Citations (PDF) |
| 395 | Performance specifications of critical results management | 1.8 | 22 | Citations (PDF) |
| 396 | Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol | 6.6 | 46 | Citations (PDF) |
| 397 | Letter to the Editor: What Is the Role of Serum Thyroglobulin Measurement in Patients With Differentiated Thyroid Cancer Treated Without Radioactive Iodine? | 4.0 | 8 | Citations (PDF) |
| 398 | Clinical performance of cardiac Troponin I: A comparison between the POCT AQT90 FLEX and the Dimension Vista analyzer in an emergency setting | 1.8 | 18 | Citations (PDF) |
| 399 | Clinical validation of the iXip index in avoiding unnecessary prostate biopsy: Results from a prospective multicenter study involving 426 patients | 1.7 | 5 | Citations (PDF) |
| 400 | Extra-analytical quality indicators and laboratory performances | 1.8 | 23 | Citations (PDF) |
| 401 | A note from the Editor in Chief regarding the Letter to the Editor “Great need for changes in higher education in Greece” | 2.3 | 0 | Citations (PDF) |
| 402 | Mass spectrometry or immunoassay: est modus in rebus | 2.3 | 26 | Citations (PDF) |
| 403 | Quality Indicators for the Total Testing Process | 1.1 | 66 | Citations (PDF) |
| 404 | Quality Indicators in Laboratory Medicine: the status of the progress of IFCC Working Group “Laboratory Errors and Patient Safety” project | 2.3 | 109 | Citations (PDF) |
| 405 | Massive Troponin Release and Normal Coronary Arteries: Where Does the Truth Lie? | 1.1 | 0 | Citations (PDF) |
| 406 | Strategies to define performance specifications in laboratory medicine: 3 years on from the Milan Strategic Conference | 2.3 | 71 | Citations (PDF) |
| 407 | New issues on measurement of B-type natriuretic peptides | 2.3 | 25 | Citations (PDF) |
| 408 | The EuBIVAS Project: Within- and Between-Subject Biological Variation Data for Serum Creatinine Using Enzymatic and Alkaline Picrate Methods and Implications for Monitoring | 1.1 | 76 | Citations (PDF) |
| 409 | Diagnostic and prognostic value of low percentage of glycosylated ferritin in acquired hemophagocytic lymphohistiocytosis: A single‐center study | 1.4 | 17 | Citations (PDF) |
| 410 | ISO 15189 Accreditation: Navigation Between Quality Management and Patient Safety | 1.7 | 33 | Citations (PDF) |
| 411 | High intensity interval resistance training (HIIRT) in older adults: Effects on body composition, strength, anabolic hormones and blood lipids | 3.7 | 35 | Citations (PDF) |
| 412 | Laboratory-related errors: you cannot manage what you don’t measure. You manage what you know and measure | 1.3 | 17 | Citations (PDF) |
| 413 | Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: a consensus statement on behalf of the IFCC Working Group “Laboratory Error and Patient Safety” and EFLM Task and Finish Group “Performance specifications for the extra-analytical phases” | 2.3 | 90 | Citations (PDF) |
| 414 | Patient and Sample Identification. Out of the Maze? | 1.7 | 28 | Citations (PDF) |
| 415 | SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells | 3.4 | 32 | Citations (PDF) |
| 416 | Definition of the upper reference limit of glycated albumin in blood donors from Italy | 2.3 | 38 | Citations (PDF) |
| 417 | Relevance of pre-analytical blood management on the emerging cardiovascular protein biomarkers TWEAK and HMGB1 and on miRNA serum and plasma profiling | 1.8 | 25 | Citations (PDF) |
| 418 | A real-world evidence-based approach to laboratory reorganization using e-Valuate benchmarking data | 2.3 | 3 | Citations (PDF) |
| 419 | Targeting errors in microbiology: the case of the Gram stain | 2.3 | 4 | Citations (PDF) |
| 420 | Quality in laboratory medicine: 50 years on | 1.8 | 45 | Citations (PDF) |
| 421 | Opportunities and drawbacks of nonstandard body fluid analysis | 2.3 | 12 | Citations (PDF) |
| 422 | Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study | 2.3 | 31 | Citations (PDF) |
| 423 | Post-standardization of routine creatinine assays: are they suitable for clinical applications | 1.7 | 32 | Citations (PDF) |
| 424 | Analytical performance of 17 general chemistry analytes across countries and across manufacturers in the INPUtS project of EQA organizers in Italy, the Netherlands, Portugal, United Kingdom and Spain | 2.3 | 40 | Citations (PDF) |
| 425 | Vitamin K plasma levels determination in human health | 2.3 | 125 | Citations (PDF) |
| 426 | The rs2274911 polymorphism in GPRC6A gene is associated with insulin resistance in normal weight and obese subjects | 2.3 | 33 | Citations (PDF) |
| 427 | Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS | 2.3 | 108 | Citations (PDF) |
| 428 | Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors | 4.4 | 22 | Citations (PDF) |
| 429 | Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients | 4.4 | 22 | Citations (PDF) |
| 430 | Clinical Laboratory Medicine: An Alliance for the Optimal Management of Acute Kidney Injury with the Use of Biomarkers | 1.3 | 0 | Citations (PDF) |
| 431 | Combined use of the multidimensional prognostic index (MPI) and procalcitonin serum levels in predicting 1-month mortality risk in older patients hospitalized with community-acquired pneumonia (CAP): a prospective study | 2.7 | 25 | Citations (PDF) |
| 432 | Calcium-sensing receptor polymorphisms increase the risk of osteoporosis in ageing males | 2.5 | 10 | Citations (PDF) |
| 433 | Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma | 2.5 | 35 | Citations (PDF) |
| 434 | Management of hemolyzed specimens | 0.2 | 2 | Citations (PDF) |
| 435 | Verification of examination procedures in clinical laboratory for imprecision, trueness and diagnostic accuracy according to ISO 15189:2012: a pragmatic approach | 2.3 | 31 | Citations (PDF) |
| 436 | The Use of Very Low Concentrations of High‐sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test | 1.7 | 74 | Citations (PDF) |
| 437 | A Case of Atypical Urticaria | 1.1 | 2 | Citations (PDF) |
| 438 | Quality performance of laboratory testing in pharmacies: a collaborative evaluation | 2.3 | 5 | Citations (PDF) |
| 439 | Laboratory economics. Risk or opportunity? | 2.3 | 14 | Citations (PDF) |
| 440 | Measurement uncertainty – a revised understanding of its calculation and use | 2.3 | 12 | Citations (PDF) |
| 441 | Pilot study on harmonization of cardiac troponin I immunoassays using patients and quality control plasma samples. On behalf of the Italian Section of the European Ligand Assay Society (ELAS) and of the Study Group on Cardiovascular Biomarkers of the Società Italiana di Biochimica Clinica (SIBioC) | 1.5 | 24 | Citations (PDF) |
| 442 | Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine | 2.3 | 29 | Citations (PDF) |
| 443 | Laboratory Critical Values Should Support Effective Clinical Decision MakingThe Authors’ Reply | 0.7 | 2 | Citations (PDF) |
| 444 | The
Choosing Wisely
campaign – don’t throw the baby out with the bathwater | 1.3 | 1 | Citations (PDF) |
| 445 | Healthcare is a giant with feet of clay | 1.3 | 1 | Citations (PDF) |
| 446 | Free light chains and heavy/light chains in monitoring POEMS patients | 2.3 | 6 | Citations (PDF) |
| 447 | Calcitonin measurement and immunoassay interference: a case report and literature review | 2.3 | 30 | Citations (PDF) |
| 448 | Sample collections from healthy volunteers for biological variation estimates’ update: a new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine | 2.3 | 104 | Citations (PDF) |
| 449 | The quality indicator paradox | 2.3 | 25 | Citations (PDF) |
| 450 | Italian Advisory Board: sFlt-1/PlGF ratio and preeclampsia, state of the art and developments in diagnostic, therapeutic and clinical management | 0.9 | 23 | Citations (PDF) |
| 451 | Serum myoglobin immunoassays: obsolete or still clinically useful? | 2.3 | 11 | Citations (PDF) |
| 452 | The use of extra-analytical phase quality indicators by clinical laboratories: the results of an international survey | 2.3 | 14 | Citations (PDF) |
| 453 | Theranos phenomenon – Part 5: Theranos’ presentation at the American Association for Clinical Chemistry Annual Conference 2016 | 2.3 | 5 | Citations (PDF) |
| 454 | Towards a new paradigm in laboratory medicine: the five rights | 2.3 | 82 | Citations (PDF) |
| 455 | Osteocalcin and Sex Hormone Binding Globulin Compete on a Specific Binding Site of GPRC6A | 2.5 | 51 | Citations (PDF) |
| 456 | Evaluation of the hypochromic erythrocyte and reticulocyte hemoglobin content provided by the Sysmex XE-5000 analyzer in diagnosis of iron deficiency erythropoiesis | 2.3 | 31 | Citations (PDF) |
| 457 | The Theranos phenomenon, scientific transparency and freedom of speech | 2.3 | 7 | Citations (PDF) |
| 458 | Atorvastatin Reduces Circulating Osteoprogenitor Cells and T‐Cell RANKL Expression in Osteoporotic Women: Implications for the Bone–Vascular Axis | 5.3 | 20 | Citations (PDF) |
| 459 | Association between intestinal permeability and faecal microbiota composition in Italian children with beta cell autoimmunity at risk for type 1 diabetes | 4.8 | 112 | Citations (PDF) |
| 460 | Assuring the quality of interpretative comments in clinical chemistry | 2.3 | 58 | Citations (PDF) |
| 461 | Letter to the Editor in reply to Dayyani and Morgenstern’s comment on the article “Identifying risk in the use of tumor markers to improve patient safety” | 2.3 | 0 | Citations (PDF) |
| 462 | CCLM Award for the Most Cited Paper Recently Published | 2.3 | 0 | Citations (PDF) |
| 463 | 25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese | 4.1 | 33 | Citations (PDF) |
| 464 | Harmonization in laboratory medicine: Requests, samples, measurements and reports | 5.4 | 69 | Citations (PDF) |
| 465 | How to report results of prothrombin and activated partial thromboplastin times | 2.3 | 31 | Citations (PDF) |
| 466 | Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T | 1.5 | 334 | Citations (PDF) |
| 467 | Fetal Endothelial Remodeling in Late-Onset Gestational Hypertension | 2.0 | 18 | Citations (PDF) |
| 468 | Building a bridge to safe diagnosis in health care. The role of the clinical laboratory | 2.3 | 45 | Citations (PDF) |
| 469 | Capillary electrophoresis for the screening and diagnosis of inherited hemoglobin disorders. Ready for prime time? | 2.3 | 12 | Citations (PDF) |
| 470 | Performance criteria and quality indicators for the post-analytical phase | 2.3 | 86 | Citations (PDF) |
| 471 | Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension | 2.3 | 80 | Citations (PDF) |
| 472 | Computer-based-limited and personalised education management maximise appropriateness of vitamin D, vitamin B12 and folate retesting | 1.7 | 27 | Citations (PDF) |
| 473 | Macroprolactin: searching for a needle in a haystack? | 2.3 | 25 | Citations (PDF) |
| 474 | Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus | 1.5 | 18 | Citations (PDF) |
| 475 | Diagnostic and prognostic implications using age- and gender-specific cut-offs for high-sensitivity cardiac troponin T — Sub-analysis from the TRAPID-AMI study | 2.2 | 117 | Citations (PDF) |
| 476 | Identifying risk in the use of tumor markers to improve patient safety | 2.3 | 11 | Citations (PDF) |
| 477 | Automated saliva processing for LC-MS/MS: Improving laboratory efficiency in cortisol and cortisone testing | 1.8 | 14 | Citations (PDF) |
| 478 | High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease | 2.3 | 41 | Citations (PDF) |
| 479 | Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review | 2.3 | 9 | Citations (PDF) |
| 480 | Glypican-1 as a highly sensitive and specific pancreatic cancer biomarker | 2.3 | 22 | Citations (PDF) |
| 481 | The Potential Role of GnRH Agonists and Antagonists in Inducing Thyroid Physiopathological Changes During IVF | 2.1 | 20 | Citations (PDF) |
| 482 | Developing GRADE outcome-based recommendations about diagnostic tests: a key role in laboratory medicine policies | 2.3 | 15 | Citations (PDF) |
| 483 | Tumor markers assay by the Lumipulse G | 2.3 | 0 | Citations (PDF) |
| 484 | Once upon a time: a tale of ISO 15189 accreditation | 2.3 | 23 | Citations (PDF) |
| 485 | A new integrated tool for assessing and monitoring test comparability and stability | 2.3 | 0 | Citations (PDF) |
| 486 | Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it | 2.3 | 16 | Citations (PDF) |
| 487 | Microarray‐based IgE detection in tears of patients with vernal keratoconjunctivitis | 2.7 | 36 | Citations (PDF) |
| 488 | Mark Graber awarded the prestigious 2014 John M. Eisenberg Patient Safety and Quality Award | 1.3 | 0 | Citations (PDF) |
| 489 | Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial | 2.3 | 42 | Citations (PDF) |
| 490 | TNFA Haplotype Genetic Testing Improves HLA in Estimating the Risk of Celiac Disease in Children | 2.3 | 7 | Citations (PDF) |
| 491 | Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients | 2.5 | 15 | Citations (PDF) |
| 492 | Immunofluorescence vs immunochemiluminescent methods: AIA 2000 vs Immulite 2000 | 1.8 | 1 | Citations (PDF) |
| 493 | Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia | 2.3 | 27 | Citations (PDF) |
| 494 | Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy | 2.3 | 6 | Citations (PDF) |
| 495 | The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway | 3.9 | 47 | Citations (PDF) |
| 496 | Thyroglobulin measurement by highly sensitive assays: focus on laboratory challenges | 2.3 | 72 | Citations (PDF) |
| 497 | Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value | 2.3 | 33 | Citations (PDF) |
| 498 | Ranking prestige of medical and laboratory technology journals | 2.3 | 5 | Citations (PDF) |
| 499 | Performance criteria and quality indicators for the pre-analytical phase | 2.3 | 100 | Citations (PDF) |
| 500 | Considerations in parathyroid hormone testing | 2.3 | 29 | Citations (PDF) |
| 501 | Acute immunomodulatory changes during controlled ovarian stimulation: evidence from the first trial investigating the short-term effects of estradiol on biomarkers and B cells involved in autoimmunity | 2.3 | 8 | Citations (PDF) |
| 502 | The standardization of the urine albumin assays: no longer deferrable | 2.3 | 3 | Citations (PDF) |
| 503 | Circulating Stem Cells Associate With Adiposity and Future Metabolic Deterioration in Healthy Subjects | 4.0 | 20 | Citations (PDF) |
| 504 | Galectin-3 Predicts Long-Term Cardiovascular Death in High-Risk Patients With Coronary Artery Disease | 6.0 | 110 | Citations (PDF) |
| 505 | Reproducibility in urine peptidome profiling using MALDI‐TOF | 3.1 | 8 | Citations (PDF) |
| 506 | Complete blood count at the ED: preanalytic variables for hemoglobin and leukocytes | 1.6 | 5 | Citations (PDF) |
| 507 | Test Utilization Is a Quality Control Issue | 0.7 | 2 | Citations (PDF) |
| 508 | Personalized medicine: moving from simple theory to daily practice | 2.3 | 19 | Citations (PDF) |
| 509 | Clinical laboratories: production industry or medical services? | 2.3 | 46 | Citations (PDF) |
| 510 | Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE) | 2.3 | 128 | Citations (PDF) |
| 511 | Could molecular assessment of calcium metabolism be a useful tool to early screen patients at risk for pre-eclampsia complicated pregnancy? Proposal and rationale | 2.3 | 9 | Citations (PDF) |
| 512 | Evaluating and using innovative technologies: a lesson from Theranos? | 2.3 | 4 | Citations (PDF) |
| 513 | Biological variation: back to basics | 2.3 | 14 | Citations (PDF) |
| 514 | The Changing Face of Hemostasis Testing in Modern Laboratories: Consolidation, Automation, and Beyond | 2.5 | 22 | Citations (PDF) |
| 515 | A contribution to detection of anticardiolipin and anti-β2glycoprotein I antibodies: Comparison between a home-made ELISA and a fluorescence enzyme immunoassay | 1.5 | 7 | Citations (PDF) |
| 516 | Can biomarkers help us to better diagnose and manage sepsis? | 1.3 | 9 | Citations (PDF) |
| 517 | An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: The Liver-FibroSTARD standards | 4.2 | 58 | Citations (PDF) |
| 518 | Salivary cortisol and cortisone by LC–MS/MS: validation, reference intervals and diagnostic accuracy in Cushing's syndrome | 1.5 | 107 | Citations (PDF) |
| 519 | Pre-analytical phase: The automated ProTube device supports quality assurance in the phlebotomy process | 1.5 | 25 | Citations (PDF) |
| 520 | The Italian External Quality Assessment (EQA) program on urinary sediment: results of the period 2012–2015 | 2.3 | 7 | Citations (PDF) |
| 521 | Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS | 4.0 | 74 | Citations (PDF) |
| 522 | Biomarkers of inflammatory bowel disease: ready for prime time? | 2.3 | 0 | Citations (PDF) |
| 523 | Diferencias de género en el uso de marcadores tumorales | 0.4 | 1 | Citations (PDF) |
| 524 | Clinical Utility of Reticulocyte Parameters | 1.1 | 155 | Citations (PDF) |
| 525 | VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells | 3.8 | 68 | Citations (PDF) |
| 526 | Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial | 23.3 | 28 | Citations (PDF) |
| 527 | Analytical validation of a Biochip prototype for integrated analysis of AFP-IgM and SCCA-IgM serum biomarkers in patients with liver cirrhosis and hepatocellular carcinoma | 2.5 | 6 | Citations (PDF) |
| 528 | IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays | 1.8 | 267 | Citations (PDF) |
| 529 | Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins | 2.5 | 24 | Citations (PDF) |
| 530 | A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naïve Patients with Non-Valvular Atrial Fibrillation | 2.3 | 30 | Citations (PDF) |
| 531 | Idiopathic hypercalciuria: O 2 − NO relationship and altered bone metabolism | 2.8 | 1 | Citations (PDF) |
| 532 | Screening with HbA1c identifies only one in two individuals with diagnosis of prediabetes at oral glucose tolerance test: findings in a real-world Caucasian population | 2.2 | 14 | Citations (PDF) |
| 533 | Technological Advances in the Hemostasis Laboratory | 2.5 | 28 | Citations (PDF) |
| 534 | Diagnosis: A new era, a new journal | 1.3 | 5 | Citations (PDF) |
| 535 | Biomarkers in the emergency department. Handle with care | 2.3 | 3 | Citations (PDF) |
| 536 | European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay | 2.3 | 126 | Citations (PDF) |
| 537 | Evaluation of clinical cases in External Quality Assessment Scheme (EQAS) for the urinary sediment | 2.3 | 8 | Citations (PDF) |
| 538 | Excellence in acute cardiac care: an overview of the seminar proceedings | 1.0 | 2 | Citations (PDF) |
| 539 | Laboratory preparedness to face infectious outbreaks. Ebola and beyond | 2.3 | 10 | Citations (PDF) |
| 540 | Interference in thyroid hormones with Roche immunoassays: an unfinished story | 2.3 | 14 | Citations (PDF) |
| 541 | CCLM Award for The Most Cited Paper Recently Published | 2.3 | 0 | Citations (PDF) |
| 542 | Asymmetric Dimethylarginine, Race, and Mortality in Hemodialysis Patients | 4.2 | 16 | Citations (PDF) |
| 543 | The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients | 2.3 | 10 | Citations (PDF) |
| 544 | Inflammatory bowel diseases: from pathogenesis to laboratory testing | 2.3 | 36 | Citations (PDF) |
| 545 | Circulating fetal cell-free DNA and prenatal molecular diagnostics: are we ready for consensus? | 2.3 | 3 | Citations (PDF) |
| 546 | Harmonization of pre-analytical quality indicators | 1.1 | 88 | Citations (PDF) |
| 547 | Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and Molecular Biology (SIBioC) | 2.3 | 9 | Citations (PDF) |
| 548 | From symptoms to biomarkers: a change of paradigm | 2.3 | 2 | Citations (PDF) |
| 549 | Adopting European Network for Health Technology Assessments (EunetHTA) core model for diagnostic technologies for improving the accuracy and appropriateness of blood gas analyzers’ assessment | 2.3 | 5 | Citations (PDF) |
| 550 | Cortisol and cortisone ratio in urine: LC-MS/MS method validation and preliminary clinical application | 2.3 | 27 | Citations (PDF) |
| 551 | Point of care testing: evolving scenarios and innovative perspectives | 2.3 | 24 | Citations (PDF) |
| 552 | Could kidney glomerular filtration impairment represent the “Achilles heel” of HE4 serum marker? A possible further implication | 2.3 | 13 | Citations (PDF) |
| 553 | Quo vadis, biomarkers? | 2.3 | 4 | Citations (PDF) |
| 554 | Harmonization of quality indicators in laboratory medicine. A preliminary consensus | 2.3 | 149 | Citations (PDF) |
| 555 | Colorectal cancer and screening programs: not only analytical issues | 2.3 | 0 | Citations (PDF) |
| 556 | Red blood cell distribution width (RDW) and human pathology. One size fits all | 2.3 | 174 | Citations (PDF) |
| 557 | A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue | 2.3 | 8 | Citations (PDF) |
| 558 | The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever | 6.1 | 157 | Citations (PDF) |
| 559 | Utilization management: A European perspective | 1.5 | 26 | Citations (PDF) |
| 560 | Quality indicators to detect pre-analytical errors in laboratory testing | 1.5 | 96 | Citations (PDF) |
| 561 | The ten commandments of laboratory testing for emergency physicians | 2.3 | 11 | Citations (PDF) |
| 562 | Promoting clinical and laboratory interaction by harmonization | 1.5 | 57 | Citations (PDF) |
| 563 | PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals | 1.5 | 16 | Citations (PDF) |
| 564 | First evaluation of a multi-capillary electrophoresis CDT assay on Helena Biosciences' V8 analyser | 1.8 | 9 | Citations (PDF) |
| 565 | A false positive case of cardiac troponin I: Which diagnostic approach? | 2.2 | 4 | Citations (PDF) |
| 566 | Diagnosis of diabetes mellitus: reiterated responsibilities for the clinical laboratory | 2.3 | 3 | Citations (PDF) |
| 567 | In search for the Holy Grail: Suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association | 1.0 | 33 | Citations (PDF) |
| 568 | Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1 | 7.9 | 35 | Citations (PDF) |
| 569 | Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: A two-year prospective observational study | 2.2 | 55 | Citations (PDF) |
| 570 | Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura | 1.8 | 8 | Citations (PDF) |
| 571 | Laboratory critical values: Automated notification supports effective clinical decision making | 1.8 | 53 | Citations (PDF) |
| 572 | Less is more, but do not throw out the baby with the bathwater either! | 1.3 | 4 | Citations (PDF) |
| 573 | Defensive medicine and diagnostic testing | 1.3 | 19 | Citations (PDF) |
| 574 | Laboratory-associated and diagnostic errors: a neglected link | 1.3 | 24 | Citations (PDF) |
| 575 | Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease | 2.2 | 13 | Citations (PDF) |
| 576 | Roles of Insulin, Age, and Asymmetric Dimethylarginine on Nitric Oxide Synthesis In Vivo | 4.2 | 17 | Citations (PDF) |
| 577 | High Prevalence of Vertebral Fractures Assessed by Quantitative Morphometry in Hemodialysis Patients, Strongly Associated with Vascular Calcifications | 2.8 | 51 | Citations (PDF) |
| 578 | Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: A comparative study | 1.5 | 19 | Citations (PDF) |
| 579 | High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome | 0.9 | 78 | Citations (PDF) |
| 580 | Ischemia-modified albumin in the era of high-sensitivity troponin immunoassays: Useful or hype? | 1.2 | 1 | Citations (PDF) |
| 581 | Multicenter evaluation of hemoglobin A1c assay on capillary electrophoresis | 1.5 | 27 | Citations (PDF) |
| 582 | CA 19-9: handle with care | 2.3 | 100 | Citations (PDF) |
| 583 | Immunosuppressant therapeutic drug monitoring by LC-MS/MS: Workflow optimization through automated processing of whole blood samples | 1.8 | 52 | Citations (PDF) |
| 584 | Non-Alcoholic Fatty Liver Disease is Not Associated with Vitamin D Deficiency in Essential Hypertension | 2.3 | 10 | Citations (PDF) |
| 585 | Quality indicators in laboratory medicine: A fundamental tool for quality and patient safety | 1.8 | 83 | Citations (PDF) |
| 586 | Serum free light chain reference values: A critical approach | 1.8 | 22 | Citations (PDF) |
| 587 | Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients | 3.6 | 14 | Citations (PDF) |
| 588 | Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives | 2.5 | 12 | Citations (PDF) |
| 589 | Biological variability of lymphocyte subsets of human adults' blood | 1.5 | 27 | Citations (PDF) |
| 590 | Harmonization in laboratory medicine: the complete picture | 2.3 | 161 | Citations (PDF) |
| 591 | Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia | 2.5 | 114 | Citations (PDF) |
| 592 | Regulation in Hemostasis and Thrombosis: Part I—In Vitro Diagnostics | 2.5 | 34 | Citations (PDF) |
| 593 | Identification and quantification of hemoglobins in whole blood: the analytical and organizational aspects of Capillarys 2 Flex Piercing compared with agarose electrophoresis and HPLC methods | 2.3 | 10 | Citations (PDF) |
| 594 | Suitability of quality control materials for prostate-specific antigen (PSA) measurement: inter-method variability of common tumor marker control materials | 2.3 | 5 | Citations (PDF) |
| 595 | CA125 reference values change in male and postmenopausal female subjects | 2.3 | 5 | Citations (PDF) |
| 596 | Personalized (laboratory) medicine: a bridge to the future | 2.3 | 16 | Citations (PDF) |
| 597 | Towards harmonization of quality indicators in laboratory medicine | 2.3 | 62 | Citations (PDF) |
| 598 | Shop for quality or quantity? Volumes and costs in clinical laboratories | 2.3 | 25 | Citations (PDF) |
| 599 | From “panic” to “critical” values: which path toward harmonization? | 2.3 | 18 | Citations (PDF) |
| 600 | The CCLM contribution to improvements in quality and patient safety | 2.3 | 44 | Citations (PDF) |
| 601 | Proposal for the use in emergency departments of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistent ST-segment elevation | 2.3 | 44 | Citations (PDF) |
| 602 | Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer | 0.9 | 15 | Citations (PDF) |
| 603 | Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal | 2.3 | 4 | Citations (PDF) |
| 604 | 50th anniversary of Clinical Chemistry and Laboratory Medicine – a historical overview1) | 2.3 | 4 | Citations (PDF) |
| 605 | Biomarkers for sepsis: an unfinished journey | 2.3 | 10 | Citations (PDF) |
| 606 | Lessons from controversy: biomarkers evaluation | 2.3 | 7 | Citations (PDF) |
| 607 | False myths and legends in laboratory diagnostics | 2.3 | 11 | Citations (PDF) |
| 608 | Biomarker research and leading causes of death worldwide: a rather feeble relationship | 2.3 | 27 | Citations (PDF) |
| 609 | Component-resolved diagnostics: laboratory results are not enough | 2.3 | 2 | Citations (PDF) |
| 610 | Age, stage and biomarkers for the definition of CKD: a construction in progress | 2.3 | 1 | Citations (PDF) |
| 611 | Fifty years of CCLM – invitation to join us for a reception in Milan | 2.3 | 0 | Citations (PDF) |
| 612 | Preanalytical quality improvement: in quality we trust | 2.3 | 186 | Citations (PDF) |
| 613 | The syndrome of the “obsessive-compulsory scientist”: a new mental disorder? | 2.3 | 5 | Citations (PDF) |
| 614 | Hemolysis-resistant reagent: another part of the puzzle for preventing errors in laboratory testing | 2.3 | 1 | Citations (PDF) |
| 615 | Anti-Müllerian hormone trend after laparoscopic surgery in women with ovarian endometrioma | 1.7 | 46 | Citations (PDF) |
| 616 | Specificity of squamous cell carcinoma antigen (SCCA)‐IgM detection in patients with HCV infection and rheumatoid factor seropositivity | 3.6 | 11 | Citations (PDF) |
| 617 | Pollen‐induced allergic rhinitis in 1360 Italian children: Comorbidities and determinants of severity | 2.7 | 81 | Citations (PDF) |
| 618 | Journal impact factor: the debate continues | 2.3 | 10 | Citations (PDF) |
| 619 | Continuous-Flow Automation and Hemolysis Index: A Crucial Combination | 3.4 | 21 | Citations (PDF) |
| 620 | Near-infrared spectroscopy as continuous real-time monitoring for kidney graft perfusion | 1.7 | 27 | Citations (PDF) |
| 621 | Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4. An In Vivo and In Vitro Study | 2.3 | 51 | Citations (PDF) |
| 622 | Urinary Biomarkers in Children with Urinary Tract Infections with and without Reflux on Antibacterial Prophylaxis with Cefaclor | 2.1 | 1 | Citations (PDF) |
| 623 | Urinary Excretion of N-Acetyl-??- D-Glucosaminidase and Epidermal Growth Factor in Paediatric Patients Receiving Cefixime Prophylaxis for Recurrent Urinary Tract Infections | 2.1 | 3 | Citations (PDF) |
| 624 | The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing–remitting multiple sclerosis | 3.9 | 23 | Citations (PDF) |
| 625 | Critical Laboratory Results: Communication Is Just One of the ProblemsThe Author’s Reply | 0.7 | 6 | Citations (PDF) |
| 626 | An Appeal to Medical Journal Editors: The Need for a Full Description of Laboratory Methods and Specimen Handling in Clinical Study Reports | 1.1 | 13 | Citations (PDF) |
| 627 | Patient Safety and Quality in Laboratory and Hemostasis Testing: A Renewed Loop? | 2.5 | 40 | Citations (PDF) |
| 628 | Biological variation and reference change values: an essential piece of the puzzle of laboratory testing | 2.3 | 27 | Citations (PDF) |
| 629 | How Well Are We Training the Next Generation of Clinical Pathologists and Clinical Laboratory Directors? A Global Perspective | 1.1 | 9 | Citations (PDF) |
| 630 | Effects of sample transportation on commonly requested laboratory tests | 2.3 | 30 | Citations (PDF) |
| 631 | Mindray BS-800M1: a new clinical chemistry system with a flexible technology meeting quality performances | 2.3 | 0 | Citations (PDF) |
| 632 | Cancer diagnosis: from dogs to DNA or from DNA to dogs? | 2.3 | 4 | Citations (PDF) |
| 633 | Phlebotomy, stat testing and laboratory organization: an intriguing relationship | 2.3 | 15 | Citations (PDF) |
| 634 | Laboratory maternal-fetal medicine: challenges and perspectives | 2.3 | 0 | Citations (PDF) |
| 635 | Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin | 2.3 | 34 | Citations (PDF) |
| 636 | Targeted therapy for HER-2: personalized medicine for her, too | 2.3 | 12 | Citations (PDF) |
| 637 | Collective opinion paper on findings of the 2011 convocation of experts on laboratory quality | 2.3 | 11 | Citations (PDF) |
| 638 | Reference values and the journal: why the past is now present | 2.3 | 14 | Citations (PDF) |
| 639 | Laboratory medicine and sports: between Scylla and Charybdis | 2.3 | 19 | Citations (PDF) |
| 640 | Exploring the Initial Steps of the Testing Process: Frequency and Nature of Pre-Preanalytic Errors | 1.1 | 124 | Citations (PDF) |
| 641 | Primary blood tubes mixing: time for updated recommendations | 2.3 | 24 | Citations (PDF) |
| 642 | Pre-analytical errors and patient safety / Preanalitičke greške i bezbednost pacijenata | 1.7 | 10 | Citations (PDF) |
| 643 | Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement | 2.3 | 27 | Citations (PDF) |
| 644 | Brazilian laboratory indicators program | 2.3 | 29 | Citations (PDF) |
| 645 | Reference change values may need some improvement but are invaluable tools in laboratory medicine | 2.3 | 15 | Citations (PDF) |
| 646 | Mild hyperparathyroidism | 2.1 | 79 | Citations (PDF) |
| 647 | Presence of anti‐ADAMTS13 antibodies in obesity | 3.0 | 14 | Citations (PDF) |
| 648 | Hyperhomocysteinemia in health and disease: where we are now, and where do we go from here? | 2.3 | 34 | Citations (PDF) |
| 649 | Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study | 4.9 | 133 | Citations (PDF) |
| 650 | Current limitations and future perspectives of the Athlete Blood Passport | 1.9 | 12 | Citations (PDF) |
| 651 | State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study | 1.5 | 76 | Citations (PDF) |
| 652 | An integrated system for monitoring the quality of sample transportation | 1.8 | 39 | Citations (PDF) |
| 653 | Su1600 Urinary Ethyl Glucuronide Improves the Detection of Alcohol Consumption in Liver Transplant Candidates and Recipients | 0.9 | 0 | Citations (PDF) |
| 654 | Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: Implications for specific immunotherapy | 6.1 | 160 | Citations (PDF) |
| 655 | Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care | 2.2 | 249 | Citations (PDF) |
| 656 | Differentiation of Cardiac and Noncardiac Dyspnea Using Bioelectrical Impedance Vector Analysis (BIVA) | 1.8 | 42 | Citations (PDF) |
| 657 | A comparative study of serum and synovial fluid lipoprotein levels in patients with various arthritides | 1.5 | 73 | Citations (PDF) |
| 658 | How to use high-sensitivity cardiac troponins in acute cardiac care | 2.2 | 730 | Citations (PDF) |
| 659 | A risk-analysis approach to the evaluation of analytical quality | 2.3 | 6 | Citations (PDF) |
| 660 | EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact | 2.3 | 123 | Citations (PDF) |
| 661 | Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial | 2.2 | 113 | Citations (PDF) |
| 662 | Low serum 25-hydroxyvitamin D levels are associated with left ventricular hypertrophy in essential hypertension | 3.2 | 17 | Citations (PDF) |
| 663 | HE4 in gynecological cancers: report of a European investigators and experts meeting | 2.3 | 38 | Citations (PDF) |
| 664 | Neutrophil gelatinase-associated lipocalin (NGAL): the laboratory perspective | 2.3 | 35 | Citations (PDF) |
| 665 | Tuning hydrophilic properties of carbon nanotubes: A challenge for enhancing selectivity in Pd catalyzed alcohol oxidation | 4.7 | 20 | Citations (PDF) |
| 666 | Full disclosure in industry-sponsored laboratory medicine research studies: statement by the consortium of laboratory medicine journal editors | 0.8 | 0 | Citations (PDF) |
| 667 | An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports | 0.8 | 3 | Citations (PDF) |
| 668 | Closing the brain-to-brain loop in laboratory testing | 2.3 | 65 | Citations (PDF) |
| 669 | High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory | 2.3 | 21 | Citations (PDF) |
| 670 | The Brain-to-Brain Loop Concept for Laboratory Testing 40 Years After Its Introduction | 0.7 | 196 | Citations (PDF) |
| 671 | Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori | 6.0 | 24 | Citations (PDF) |
| 672 | Quality Indicators in Laboratory Medicine: from theory to practice | 2.3 | 124 | Citations (PDF) |
| 673 | Preanalytical quality improvement: from dream to reality | 2.3 | 316 | Citations (PDF) |
| 674 | Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories | 5.4 | 181 | Citations (PDF) |
| 675 | Quality indicators for laboratory diagnostics: consensus is needed | 1.7 | 32 | Citations (PDF) |
| 676 | MYELOPEROXIDASE HAS NO ROLE IN DIAGNOSIS OF ACUTE CORONARY SYNDROMES IN SUBJECTS WITH CHEST PAIN IN EMERGENCY DEPARTMENT | 2.3 | 1 | Citations (PDF) |
| 677 | New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis | 1.5 | 19 | Citations (PDF) |
| 678 | Anti-Helicobacter pylori antibodies in cervical mucus: a new cause of infertility | 0.9 | 30 | Citations (PDF) |
| 679 | TLR2 and TLR4 Up-regulation and Colonization of the Ileal Mucosa by Clostridiaceae spp. in Chronic/Relapsing Pouchitis | 1.6 | 26 | Citations (PDF) |
| 680 | High-Sensitive Troponin Testing and the “Runner's Syndrome” | 0.8 | 6 | Citations (PDF) |
| 681 | Identification errors in the blood transfusion laboratory: A still relevant issue for patient safety | 0.9 | 29 | Citations (PDF) |
| 682 | Effects of Long-Term Administration of Recombinant Human Protein C in Xenografted Primates | 2.1 | 14 | Citations (PDF) |
| 683 | Interleukin 1β and tumor necrosis factor-α polymorphisms in autoimmune gastritis | 1.3 | 1 | Citations (PDF) |
| 684 | Pancreatic Cancer Alters Human CD4+ T Lymphocyte Function | 0.9 | 19 | Citations (PDF) |
| 685 | Androgens modulate osteocalcin release by human visceral adipose tissue | 2.3 | 21 | Citations (PDF) |
| 686 | Direct-to-consumer testing: more risks than opportunities | 3.0 | 45 | Citations (PDF) |
| 687 | Further advances of normalizing the Preventable Harm Index | 2.0 | 0 | Citations (PDF) |
| 688 | Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N‐terminal peptide (NT‐S100A8) | 4.1 | 17 | Citations (PDF) |
| 689 | VKORC1
,
CYP2C9
and
CYP4F2
Genetic-based Algorithm for Warfarin Dosing: An Italian Retrospective Study | 1.5 | 64 | Citations (PDF) |
| 690 | Direct-to-Consumer Genomewide Profiling | 34.5 | 6 | Citations (PDF) |
| 691 | Laboratory medicine: an essential partner in the care of cancer patients | 2.3 | 10 | Citations (PDF) |
| 692 | Pharmacogenomics of alcohol metabolism: implications for legal testing | 2.3 | 8 | Citations (PDF) |
| 693 | Athlete's biological passport: to test or not to test? | 2.3 | 17 | Citations (PDF) |
| 694 | ROMA or death: advances in epithelial ovarian cancer diagnosis | 2.3 | 10 | Citations (PDF) |
| 695 | Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea | 2.3 | 1 | Citations (PDF) |
| 696 | Economic evidence in decision-making process in laboratory medicine | 2.3 | 13 | Citations (PDF) |
| 697 | Circulating macrocomplexes: old wine in new bottles? | 2.3 | 8 | Citations (PDF) |
| 698 | Pneumatic tube delivery systems for patient samples: evidence of quality and quality of evidence | 2.3 | 25 | Citations (PDF) |
| 699 | Thank you, indeed! | 2.3 | 6 | Citations (PDF) |
| 700 | Regulation of in vitro diagnostics (IVDs) for use in clinical diagnostic laboratories: towards the light or dark in clinical laboratory testing? | 2.3 | 11 | Citations (PDF) |
| 701 | Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors | 2.3 | 13 | Citations (PDF) |
| 702 | Collective opinion paper on findings of the 2010 convocation of experts on laboratory quality | 2.3 | 57 | Citations (PDF) |
| 703 | Non-invasive assessment of liver fibrosis: it is time for laboratory medicine | 2.3 | 23 | Citations (PDF) |
| 704 | Nuclear and radiation accidents: the next and further challenge for laboratory diagnostics | 2.3 | 1 | Citations (PDF) |
| 705 | Appropriate labelling of blood collection tubes: a step ahead towards patient’s safety | 2.3 | 29 | Citations (PDF) |
| 706 | Chronic Anemia Due to Mitomycin C Is Drug Dose-Dependent, Normocytic, Progressive, Related to Erythropoietin Levels and Quantitatively Predictable: Implications for Radiochemotherapy | 1.5 | 1 | Citations (PDF) |
| 707 | Full Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors | 1.1 | 2 | Citations (PDF) |
| 708 | Widespread Increase in Myeloid Calcifying Cells Contributes to Ectopic Vascular Calcification in Type 2 Diabetes | 13.1 | 115 | Citations (PDF) |
| 709 | Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors | 1.7 | 0 | Citations (PDF) |
| 710 | Serum YKL-40 following resection for cerebral glioblastoma | 2.5 | 52 | Citations (PDF) |
| 711 | Molecular Refinement of Clinical Staging in Hepatocellular Carcinoma Patients Evaluated for Potentially Curative Therapies | 2.3 | 4 | Citations (PDF) |
| 712 | Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis | 2.3 | 95 | Citations (PDF) |
| 713 | Markers of eosinophilic and neutrophilic inflammation in bronchoalveolar lavage of asthmatic and atopic children | 6.7 | 34 | Citations (PDF) |
| 714 | Analogs of Vitamin E Epitomized by α-Tocopheryl Succinate for Pancreatic Cancer Treatment | 0.9 | 9 | Citations (PDF) |
| 715 | Pathogenesis of Helicobacter pylori Infection | 3.8 | 113 | Citations (PDF) |
| 716 | Is ANCA really related to chronic liver disease? | 3.9 | 0 | Citations (PDF) |
| 717 | Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up study | 3.7 | 250 | Citations (PDF) |
| 718 | Diagnosis of Iron Deficiency in Patients Undergoing Hemodialysis | 0.7 | 72 | Citations (PDF) |
| 719 | Rapid intraoperative parathyroid hormone assay in fine needle aspiration for differential diagnosis in thyroid and parathyroid surgery | 2.3 | 15 | Citations (PDF) |
| 720 | Prognostic Value of Isolated Troponin I Elevation After Percutaneous Coronary Intervention | 4.8 | 66 | Citations (PDF) |
| 721 | Kinetics of highly sensitive troponin I and T after eccentric exercise | 2.3 | 6 | Citations (PDF) |
| 722 | Laboratory medicine and natural disasters: are we ready for the challenge? | 2.3 | 20 | Citations (PDF) |
| 723 | Biochemical and imaging biomarkers: the search for the Holy Grail | 2.3 | 5 | Citations (PDF) |
| 724 | Darwinian evolution or regression? The fate of laboratory professionals | 2.3 | 1 | Citations (PDF) |
| 725 | The Esr Test: An Old Test With New Contents | 1.7 | 0 | Citations (PDF) |
| 726 | Assessment of critical values policies in Italian institutions: comparison with the US situation | 2.3 | 50 | Citations (PDF) |
| 727 | Collective opinion paper on findings of the 2009 convocation of experts on quality control | 2.3 | 24 | Citations (PDF) |
| 728 | PATHFAST™ NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay | 2.3 | 19 | Citations (PDF) |
| 729 | Evaluating laboratory diagnostic tests and translational research | 2.3 | 25 | Citations (PDF) |
| 730 | Rapid diagnosis of swine-origin influenza A (H1N1) virus (S-OIV): useful or hype? | 2.3 | 20 | Citations (PDF) |
| 731 | Reference values: still a critical issue in laboratory medicine | 2.3 | 3 | Citations (PDF) |
| 732 | Skeletal muscle biomarkers: not new but still interesting diagnostic tools | 2.3 | 9 | Citations (PDF) |
| 733 | The “Obamanomics”: a revolution in laboratory diagnostics | 2.3 | 5 | Citations (PDF) |
| 734 | Laboratory testing in pharmacies | 2.3 | 30 | Citations (PDF) |
| 735 | Proteomic analysis of venous thromboembolism | 2.0 | 6 | Citations (PDF) |
| 736 | Vitamins B2 and B6 and Genetic Polymorphisms Related to One-Carbon Metabolism as Risk Factors for Gastric Adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition | 1.1 | 41 | Citations (PDF) |
| 737 | The “hospital central laboratory”: automation, integration and clinical usefulness | 2.3 | 67 | Citations (PDF) |
| 738 | Atorvastatin Reduces Macrophage Accumulation in Atherosclerotic Plaques | 5.9 | 64 | Citations (PDF) |
| 739 | Evidence for Osteocalcin Production by Adipose Tissue and Its Role in Human Metabolism | 4.0 | 107 | Citations (PDF) |
| 740 | The detection and prevention of errors in laboratory medicine | 1.7 | 433 | Citations (PDF) |
| 741 | Improving the post-analytical phase | 2.3 | 28 | Citations (PDF) |
| 742 | Medical Errors: Pre-Analytical Issue in Patient Safety | 1.7 | 15 | Citations (PDF) |
| 743 | Laboratory “incidentalomas”: Facts or fiction? | 2.7 | 6 | Citations (PDF) |
| 744 | Evaluation of erythrocyte band 3 phosphotyrosine level, glutathione content, CA-125, and human epididymal secretory protein E4 as combined parameters in endometriosis | 2.9 | 38 | Citations (PDF) |
| 745 | An Italian External Quality Assessment (EQA) program on urinary sediment | 1.5 | 20 | Citations (PDF) |
| 746 | HPLC determination of plasma dimethylarginines: Method validation and preliminary clinical application | 1.5 | 26 | Citations (PDF) |
| 747 | Sensitive Cardiac Troponin T Assay | 34.5 | 18 | Citations (PDF) |
| 748 | Notification of Abnormal and Critical Values: The Road Ahead | 2.0 | 3 | Citations (PDF) |
| 749 | Recommendations for the use of cardiac troponin measurement in acute cardiac care | 2.2 | 575 | Citations (PDF) |
| 750 | Automated reticulocyte counting: state of the art and clinical applications in the evaluation of erythropoiesis | 2.3 | 94 | Citations (PDF) |
| 751 | The measurement of cardiac troponins in patients undergoing major orthopaedic surgery | 1.9 | 1 | Citations (PDF) |
| 752 | Quality in laboratory diagnostics: from theory to practice | 1.1 | 39 | Citations (PDF) |
| 753 | The role of the External Quality Assessment | 1.1 | 33 | Citations (PDF) |
| 754 | Notification of critical values | 1.1 | 5 | Citations (PDF) |
| 755 | Multicenter evaluation of the hemolysis index in automated clinical chemistry systems | 2.3 | 117 | Citations (PDF) |
| 756 | Cardiac troponin I at birth is of fetal-neonatal origin | 2.8 | 10 | Citations (PDF) |
| 757 | Antibodies against Synthetic Deamidated Gliadin Peptides for Celiac Disease Diagnosis and Follow-Up in Children | 1.1 | 82 | Citations (PDF) |
| 758 | The journal impact factor: navigating between Scylla and Charybdis | 2.3 | 6 | Citations (PDF) |
| 759 | Hemolysis index: quality indicator or criterion for sample rejection? | 2.3 | 62 | Citations (PDF) |
| 760 | Cardiac troponins: what we knew, what we know – where are we now? | 2.3 | 15 | Citations (PDF) |
| 761 | Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study | 2.3 | 60 | Citations (PDF) |
| 762 | Precision performance at low levels and 99th percentile concentration of the Access® AccuTnI® assay on two different platforms | 2.3 | 23 | Citations (PDF) |
| 763 | Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry | 2.3 | 32 | Citations (PDF) |
| 764 | Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications | 2.3 | 38 | Citations (PDF) |
| 765 | Prostate-specific antigen-based screening for prostate cancer in the third millennium: Useful or hype? | 3.8 | 24 | Citations (PDF) |
| 766 | Prostate-Specific Antigen, Prostate Cancer, and Disorders of Hemostasis | 2.5 | 16 | Citations (PDF) |
| 767 | Evaluation of analytical performance of the Pathfast® cardiac troponin I | 2.3 | 12 | Citations (PDF) |
| 768 | Change through continuity | 2.3 | 1 | Citations (PDF) |
| 769 | Evaluation of Effectiveness of a Computerized Notification System for Reporting Critical Values | 0.7 | 91 | Citations (PDF) |
| 770 | HER2: Closing the Gap Between Laboratory Testing and Clinical Practice | 0.7 | 2 | Citations (PDF) |
| 771 | Recent advances in diagnostic technologies for autoimmune diseases | 7.1 | 35 | Citations (PDF) |
| 772 | What is behind the presence of anti‐neutrophil cytoplasmatic antibodies in chronic liver disease? | 3.9 | 13 | Citations (PDF) |
| 773 | Phosphorylated insulin‐like growth factor binding protein‐1 in cervical secretions and sonographic cervical length in the prediction of spontaneous preterm delivery | 4.0 | 24 | Citations (PDF) |
| 774 | Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics | 2.3 | 132 | Citations (PDF) |
| 775 | Creatine-kinase MB mass: Age and sex-associated reference limits in two different platforms that use the same method | 1.5 | 9 | Citations (PDF) |
| 776 | GastroPanel: Evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children | 1.5 | 37 | Citations (PDF) |
| 777 | Heterophilic antibody interference in a non-endogenous molecule assay: An apparent elevation in the tacrolimus concentration | 1.5 | 37 | Citations (PDF) |
| 778 | Interpretative commenting: A tool for improving the laboratory–clinical interface | 1.5 | 70 | Citations (PDF) |
| 779 | Post-analytical errors with portable glucose meters in the hospital setting | 1.5 | 36 | Citations (PDF) |
| 780 | Does POCT reduce the risk of error in laboratory testing? | 1.5 | 98 | Citations (PDF) |
| 781 | Exploring the iceberg of errors in laboratory medicine | 1.5 | 234 | Citations (PDF) |
| 782 | The IFCC Working Group on laboratory errors and patient safety | 1.5 | 145 | Citations (PDF) |
| 783 | Interpretative reports and critical values | 1.5 | 47 | Citations (PDF) |
| 784 | Performance characteristics of laboratory testing and clinical outcomes | 1.5 | 4 | Citations (PDF) |
| 785 | The importance of incident reporting in laboratory diagnostics | 1.2 | 14 | Citations (PDF) |
| 786 | T1599 The Influence of Subclinical Intestinal Inflammation On the Systemic Inflammatory Status in Crohn's Disease: A Fire Burning Under Ashes | 0.9 | 0 | Citations (PDF) |
| 787 | Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies | 1.0 | 23 | Citations (PDF) |
| 788 | Interleukin-6 and tumor necrosis factor-α as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide | 1.2 | 11 | Citations (PDF) |
| 789 | Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy | 3.9 | 20 | Citations (PDF) |
| 790 | Cytokine network in rectal mucosa in perianal Crohnʼs disease: Relations with inflammatory parameters and need for surgery | 2.9 | 31 | Citations (PDF) |
| 791 | Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Results from a prospective, unrandomized, comparative study | 3.2 | 73 | Citations (PDF) |
| 792 | Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer | 2.9 | 93 | Citations (PDF) |
| 793 | IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections | 1.5 | 16 | Citations (PDF) |
| 794 | The changing scenario in laboratory medicine and the role of laboratory professionals in translational medicine | 1.5 | 16 | Citations (PDF) |
| 795 | DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study | 4.9 | 70 | Citations (PDF) |
| 796 | Hypoxia Inducible Factor-1α Inactivation Unveils a Link between Tumor Cell Metabolism and Hypoxia-Induced Cell Death | 3.4 | 41 | Citations (PDF) |
| 797 | Clinical Relevance of Helicobacter pylori cagA and vacA Gene Polymorphisms | 0.9 | 361 | Citations (PDF) |
| 798 | M1986 The Tumor Marker Behavior of Proteolytic Enzymes in Colorectal Cancer | 0.9 | 0 | Citations (PDF) |
| 799 | Celiac disease in North Italian patients with autoimmune thyroid diseases | 3.1 | 50 | Citations (PDF) |
| 800 | Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories | 2.3 | 397 | Citations (PDF) |
| 801 | Pharmacy-based laboratory services: past or future and risk or opportunity? | 2.3 | 6 | Citations (PDF) |
| 802 | Time to reconsider the clinical value of immunoglobulin G4 to foods? | 2.3 | 9 | Citations (PDF) |
| 803 | CCLM: Evolving to meet the needs of today's laboratory professionals and scientists | 2.3 | 7 | Citations (PDF) |
| 804 | An expert system for the classification of serum protein electrophoresis patterns | 2.3 | 15 | Citations (PDF) |
| 805 | Quality Control in Coagulation Testing | 2.5 | 18 | Citations (PDF) |
| 806 | Automated Blood Cell Counts | 0.7 | 348 | Citations (PDF) |
| 807 | Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers | 2.0 | 32 | Citations (PDF) |
| 808 | The Paradox in Translational Medicine | 1.1 | 28 | Citations (PDF) |
| 809 | Laboratory Medicine: Value for Patients Is the Goal | 1.1 | 37 | Citations (PDF) |
| 810 | Risk management in laboratory medicine: quality assurance programs and professional competence | 2.3 | 35 | Citations (PDF) |
| 811 | Renal Dysfunction Is a Confounder for Plasma Natriuretic Peptides in Detecting Heart Dysfunction in Uremic and Idiopathic Dilated Cardiomyopathies | 1.1 | 25 | Citations (PDF) |
| 812 | Cytokines in Human Colostrum and Neonatal Jaundice | 2.2 | 29 | Citations (PDF) |
| 813 | Procalcitonin and C-Reactive Protein as Diagnostic Markers of Severe Bacterial Infections in Febrile Infants and Children in the Emergency Department | 1.1 | 229 | Citations (PDF) |
| 814 | Reply to the Letter written by Hardeman | 2.3 | 1 | Citations (PDF) |
| 815 | In vivo and in vitro allergy diagnostics: it's time to reappraise the costs | 2.3 | 10 | Citations (PDF) |
| 816 | Natriuretic peptides. The hormones of the heart | 2.3 | 0 | Citations (PDF) |
| 817 | Accreditation of medical laboratories in the European Union | 2.3 | 34 | Citations (PDF) |
| 818 | Quality specifications: self pleasure for clinical laboratories or added value for patient management? | 2.3 | 19 | Citations (PDF) |
| 819 | One hundred years of laboratory testing and patient safety | 2.3 | 22 | Citations (PDF) |
| 820 | What's next in translational medicine? | 6.2 | 119 | Citations (PDF) |
| 821 | Biochemical Markers for the Early Assessment of Neonatal Sepsis: the Role of Procalcitonin | 1.5 | 21 | Citations (PDF) |
| 822 | Suicide Gene Therapy With the Yeast Fusion Gene Cytosine Deaminase/Uracil Phosphoribosyltransferase Is Not Enough for Pancreatic Cancer | 0.9 | 9 | Citations (PDF) |
| 823 | Non-invasive assessment of chronic liver and gastric diseases | 1.5 | 20 | Citations (PDF) |
| 824 | DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis | 1.5 | 49 | Citations (PDF) |
| 825 | Enzymes in feces: Useful markers of chronic inflammatory bowel disease | 1.5 | 106 | Citations (PDF) |
| 826 | New biochemical markers: From bench to bedside | 1.5 | 20 | Citations (PDF) |
| 827 | Errors in laboratory medicine and patient safety: the road ahead | 2.3 | 128 | Citations (PDF) |
| 828 | National survey on critical values reporting in a cohort of Italian laboratories | 2.3 | 36 | Citations (PDF) |
| 829 | Errors in a Stat Laboratory: Types and Frequencies 10 Years Later | 1.1 | 573 | Citations (PDF) |
| 830 | Process and risk analysis to reduce errors in clinical laboratories | 2.3 | 24 | Citations (PDF) |
| 831 | CagA+Helicobacter pyloriinfection and gastric cancer risk in the EPIC-EURGAST study | 4.3 | 119 | Citations (PDF) |
| 832 | A new turbidimetric standard to improve the quality assurance of the erythrocyte sedimentation rate measurement | 1.8 | 14 | Citations (PDF) |
| 833 | Fecal Lactoferrin and Calprotectin After Ileocolonic Resection for Crohn's Disease | 1.7 | 89 | Citations (PDF) |
| 834 | Clarithromycin Resistance, Tumor Necrosis Factor Alpha Gene Polymorphism and Mucosal Inflammation Affect H. pylori Eradication Success | 1.7 | 12 | Citations (PDF) |
| 835 | Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology | 1.8 | 41 | Citations (PDF) |
| 836 | Laboratory errors: How to improve pre- and post-analytical phases? | 1.1 | 24 | Citations (PDF) |
| 837 | Clinical Governance: from clinical risk management to continuous quality improvement | 2.3 | 27 | Citations (PDF) |
| 838 | Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause? | 1.5 | 80 | Citations (PDF) |
| 839 | Managing transferability of laboratory data | 1.5 | 31 | Citations (PDF) |
| 840 | Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1 −/− epithelial ovarian cancers | 4.9 | 30 | Citations (PDF) |
| 841 | Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C | 4.2 | 251 | Citations (PDF) |
| 842 | Laboratory Investigation for the Early Diagnosis and Monitoring of Neonatal Urinary Tract Infections: the Present Situation and Future Perspectives | 1.5 | 4 | Citations (PDF) |
| 843 | Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome | 0.9 | 236 | Citations (PDF) |
| 844 | Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study | 0.1 | 150 | Citations (PDF) |
| 845 | Evaluation of a new capillary zone electrophoresis system for the identification and typing of Bence Jones Protein | 1.8 | 12 | Citations (PDF) |
| 846 | Quantitative PSA mRNA determination in blood: A biochemical tool for scoring localized prostate cancer | 1.8 | 10 | Citations (PDF) |
| 847 | Usefulness of Serum Pepsinogens in Helicobacter pylori Chronic Gastritis: Relationship With Inflammation, Activity, and Density of the Bacterium | 2.1 | 56 | Citations (PDF) |
| 848 | Towards quality specifications in extra-analytical phases of laboratory services: What information on quality specifications should be communicated to clinicians, and how? | 0.8 | 1 | Citations (PDF) |
| 849 | The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients | 1.7 | 45 | Citations (PDF) |
| 850 | Th1- and Th2-type cytokines in chronic ocular allergy | 1.8 | 93 | Citations (PDF) |
| 851 | Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC–EURGAST) | 4.3 | 308 | Citations (PDF) |
| 852 | Translational Research Involving New Biomarkers of Disease | 0.7 | 17 | Citations (PDF) |
| 853 | Insights in the Laboratory Diagnosis of Celiac Disease | 1.7 | 5 | Citations (PDF) |
| 854 | Mitochondrial DNA D-Loop in Pancreatic Cancer | 0.7 | 79 | Citations (PDF) |
| 855 | Medical Biomethods Handbook. John M. Walker and Ralph Rapley. Totowa, NJ: Humana Press, 2005, 656 pp. plus CD-ROM, hardcover, $150.00. ISBN 1-58829-288-6. | 1.1 | 0 | Citations (PDF) |
| 856 | C-Reactive Protein in Hypertensive Disorders in Pregnancy | 1.7 | 42 | Citations (PDF) |
| 857 | Natriuretic peptides and evidence-based quality specifications | 2.3 | 1 | Citations (PDF) |
| 858 | External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine | 2.3 | 48 | Citations (PDF) |
| 859 | Laboratory network of excellence: enhancing patient safety and service effectiveness / Labor-Network of Excellence: bessere Sicherheit für Patienten und effektivere Labordienstleistungen | 0.0 | 0 | Citations (PDF) |
| 860 | Preanalytical variability: the dark side of the moon in laboratory testing | 2.3 | 340 | Citations (PDF) |
| 861 | Laboratory network of excellence: enhancing patient safety and service effectiveness | 2.3 | 84 | Citations (PDF) |
| 862 | Analytical and clinical evaluation of a new heart-type fatty acid-binding protein automated assay | 2.3 | 13 | Citations (PDF) |
| 863 | Research translation: a new frontier for clinical laboratories | 2.3 | 40 | Citations (PDF) |
| 864 | Preanalytical variability: the dark side of the moon in laboratory testing / Präanalytische Variabilität: die Schattenseite klinischer Laboruntersuchungen | 0.0 | 1 | Citations (PDF) |
| 865 | Western Blot Immunoassay for HSP-70 Antibodies in Idiopathic Tinnitus: A Preliminary Report | 1.4 | 7 | Citations (PDF) |
| 866 | Innotrac Aio!: a point-of-care or a routine analyzer? Analytical performance and plasma/whole blood comparison | 2.3 | 1 | Citations (PDF) |
| 867 | Meat Intake and Risk of Stomach and Esophageal Adenocarcinoma Within the European Prospective Investigation Into Cancer and Nutrition (EPIC) | 4.6 | 319 | Citations (PDF) |
| 868 | Measurement of serum monoclonal components: comparison between densitometry and capillary zone electrophoresis | 2.3 | 25 | Citations (PDF) |
| 869 | Errors in clinical laboratories or errors in laboratory medicine? | 2.3 | 565 | Citations (PDF) |
| 870 | Effects of Long-term Administration of High-dose Recombinant Human Antithrombin in Immunosuppressed Primate Recipients of Porcine Xenografts | 2.1 | 31 | Citations (PDF) |
| 871 | Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload | 2.9 | 8 | Citations (PDF) |
| 872 | NT-proBNP in the differential diagnosis of acute dyspnea in the emergency department | 1.8 | 12 | Citations (PDF) |
| 873 | Urinary ET-1, AVP and sodium in premature infants treated with indomethacin and ibuprofen for patent ductus arteriosus | 1.7 | 9 | Citations (PDF) |
| 874 | Pancreatic Cancer Cells Invasiveness is Mainly Affected by Interleukin-1β not by Transforming Growth Factor-β1 | 1.9 | 33 | Citations (PDF) |
| 875 | Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes | 0.4 | 261 | Citations (PDF) |
| 876 | Effect of Maternal Smoking on Breast Milk Interleukin-1α, β-Endorphin, and Leptin Concentrations | 8.3 | 30 | Citations (PDF) |
| 877 | Pentosidine Plasma Levels and Relation with Metabolic Control in Diabetic Patients | 1.8 | 19 | Citations (PDF) |
| 878 | New Biochemical Insights into the Pathogenesis of Osteoarthritis and the Role of Laboratory Investigations in Clinical Assessment | 5.4 | 41 | Citations (PDF) |
| 879 | Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study | 2.2 | 179 | Citations (PDF) |
| 880 | Reply to W.G. Wood. Questionable results – who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 | 2.3 | 0 | Citations (PDF) |
| 881 | The future of clinical laboratories: more testing or knowledge services? | 2.3 | 29 | Citations (PDF) |
| 882 | Proteomics: The next revolution in laboratory medicine? | 1.5 | 64 | Citations (PDF) |
| 883 | Pancreatic cancer-associated diabetes mellitus: An open field for proteomic applications | 1.5 | 35 | Citations (PDF) |
| 884 | Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer | 1.5 | 40 | Citations (PDF) |
| 885 | Pro- and anti-inflammatory cytokines gene polymorphisms and infection: interactions influence outcome | 3.5 | 191 | Citations (PDF) |
| 886 | Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease | 2.3 | 15 | Citations (PDF) |
| 887 | Effect of inhalation of thermal water on airway inflammation in chronic obstructive pulmonary disease | 2.6 | 27 | Citations (PDF) |
| 888 | Anemia and ischemia: Myocardial injury in patients with gastrointestinal bleeding | 2.0 | 42 | Citations (PDF) |
| 889 | Anti-heparan sulphate antibodies and homocysteine in dementia: markers of vascular pathology? | 2.1 | 4 | Citations (PDF) |
| 890 | External quality assessment programs: Past, present and future | 0.1 | 3 | Citations (PDF) |
| 891 | Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels | 2.3 | 1 | Citations (PDF) |
| 892 | External Quality Assessment for biochemical markers of myocardial damage: an Italian experience | 2.3 | 7 | Citations (PDF) |
| 893 | Towards quality specifications in extra-analytical phases of laboratory activity | 2.3 | 38 | Citations (PDF) |
| 894 | A Large Deletion due to a New Mutation (Intron 13/Exon 23) in a Sporadic Case of Severe Hemophilia A | 1.7 | 3 | Citations (PDF) |
| 895 | Allergy to wine | 6.7 | 19 | Citations (PDF) |
| 896 | Non-invasive diagnosis of Helicobacter pylori infection: simplified 13C-urea breath test, stool antigen testing, or DNA PCR in human feces in a clinical laboratory setting? | 1.8 | 22 | Citations (PDF) |
| 897 | H. pyloriInfection: Bacterial Virulence Factors and Cytokine Gene Polymorphisms as Determinants of Infection Outcome | 5.4 | 23 | Citations (PDF) |
| 898 | Biochemistry and Clinical Role of Human Cystatin C | 5.4 | 267 | Citations (PDF) |
| 899 | Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides | 1.5 | 9 | Citations (PDF) |
| 900 | Quality specifications for biochemical markers of myocardial injury | 1.5 | 19 | Citations (PDF) |
| 901 | Requirements for improving quality in the measurement of bone markers | 1.5 | 24 | Citations (PDF) |
| 902 | Quality specifications in EQA schemes: from theory to practice | 1.5 | 35 | Citations (PDF) |
| 903 | What information on quality specifications should be communicated to clinicians, and how? | 1.5 | 42 | Citations (PDF) |
| 904 | Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma | 1.5 | 33 | Citations (PDF) |
| 905 | Helicobacter pylori Infection in Children and Adults: A Single Pathogen But a Different Pathology | 3.8 | 37 | Citations (PDF) |
| 906 | Helicobacter pylori Infection and Gastric Autoimmune Diseases: Is There a Link? | 3.8 | 61 | Citations (PDF) |
| 907 | Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation | 2.5 | 14 | Citations (PDF) |
| 908 | Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA | 2.1 | 40 | Citations (PDF) |
| 909 | Clinical value and measurement of specific IgE | 1.8 | 34 | Citations (PDF) |
| 910 | Appropriateness in programs for continuous quality improvement in clinical laboratories | 1.5 | 52 | Citations (PDF) |
| 911 | Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors | 1.5 | 61 | Citations (PDF) |
| 912 | Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness | 1.5 | 33 | Citations (PDF) |
| 913 | Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs | 1.5 | 2 | Citations (PDF) |
| 914 | Effects of Th2 Cytokines on Expression of Collagen, MMP-1, and TIMP-1 in Conjunctival Fibroblasts 2003, 44, 183 | | 74 | Citations (PDF) |
| 915 | The Art of Chemistry—Myths, Medicines, and Materials. Arthur Greenberg. Hoboken, NJ: John Wiley & Sons, Inc, 2003, 357 pp., $ 59.95. ISBN 0-474-07L80-3. | 1.1 | 0 | Citations (PDF) |
| 916 | Erythrocyte Sedimentation Rate: Innovative Techniques for an Obsolete Test? | 2.3 | 28 | Citations (PDF) |
| 917 | Helicobacter pylori babA2, cagA, and s1 vacA genes work synergistically in causing intestinal metaplasia | 1.7 | 128 | Citations (PDF) |
| 918 | Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics | 5.5 | 115 | Citations (PDF) |
| 919 | YKL-40 as a Marker of Joint Involvement in Inflammatory Bowel Disease | 1.1 | 36 | Citations (PDF) |
| 920 | Celiac Disease and Type 1 Diabetes | 6.2 | 15 | Citations (PDF) |
| 921 | Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension | 5.5 | 34 | Citations (PDF) |
| 922 | Tear Levels and Activity of Matrix Metalloproteinase (MMP)-1 and MMP-9 in Vernal Keratoconjunctivitis 2003, 44, 3052 | | 122 | Citations (PDF) |
| 923 | Tumor Necrosis Factor-Alpha (TNF-α) in Seasonal Allergic Conjunctivitis and Vernal Keratoconjunctivitis | 1.3 | 43 | Citations (PDF) |
| 924 | Cardiac troponin I, cardiac troponin T and creatine kinase MB concentrations in umbilical cord blood of healthy term neonates | 1.6 | 41 | Citations (PDF) |
| 925 | Histamine-induced cytokine production and ICAM-1 expression in human conjunctival fibroblasts | 2.1 | 33 | Citations (PDF) |
| 926 | Process Control Reduces the Laboratory Turnaround Time | 2.3 | 19 | Citations (PDF) |
| 927 | Erythrocyte Sedimentation Rate | 0.7 | 86 | Citations (PDF) |
| 928 | Netilmicin Effect on Urinary Retinol Binding Protein (RBP) and N-Acetyl-Beta-D-Glucosaminidase (NAG) in Preterm Newborns with and without Anoxia | 1.5 | 5 | Citations (PDF) |
| 929 | Clinical Significance of Cytokine Determination in Synovial Fluid | 5.4 | 49 | Citations (PDF) |
| 930 | Determination of the Length of Sedimentation Reaction (Erythrocyte Sedimentation Rate) in Non-Anticoagulated Blood with the Microtest 1 | 2.3 | 13 | Citations (PDF) |
| 931 | Retrovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene Transfer in Pancreatic Cancer Cell Lines: An Incomplete Antitumor Effect | 0.9 | 17 | Citations (PDF) |
| 932 | Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children | 0.5 | 37 | Citations (PDF) |
| 933 | Putative Pancreatic Cancer-Associated Diabetogenic Factor: 2030 MW Peptide | 0.9 | 71 | Citations (PDF) |
| 934 | Biochemical markers for the prediction of spontaneous pre-term birth | 1.8 | 43 | Citations (PDF) |
| 935 | Charting the course of medical laboratories in a changing environment | 1.5 | 62 | Citations (PDF) |
| 936 | Continuing medical education: a challenge to the Italian Scientific Societies of Laboratory Medicine | 1.5 | 5 | Citations (PDF) |
| 937 | Sex hormone profile and endometrial cancer risk in primary biliary cirrhosis: a case-control study | 0.9 | 24 | Citations (PDF) |
| 938 | False-Positive Troponin I Attributed to a Macrocomplex | 1.1 | 55 | Citations (PDF) |
| 939 | Diagnostic Value of Plasma Cystatin C as a Glomerular Filtration Marker in Decompensated Liver Cirrhosis | 1.1 | 144 | Citations (PDF) |
| 940 | Performance of a Revised Cardiac Troponin Method That Minimizes Interferences from Heterophilic Antibodies | 1.1 | 48 | Citations (PDF) |
| 941 | Errors in Laboratory Medicine | 1.1 | 714 | Citations (PDF) |
| 942 | Serologic Testing for Celiac Disease | 1.1 | 23 | Citations (PDF) |
| 943 | Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients | 5.3 | 249 | Citations (PDF) |
| 944 | Predictive value of amniotic fluid cystatin C levels for the early identification of fetuses with obstructive uropathies | 3.1 | 25 | Citations (PDF) |
| 945 | Serum-mediated relaxant response to toluene diisocyanate (TDI) in isolated guinea-pig bronchi | 2.6 | 3 | Citations (PDF) |
| 946 | Analysis of Gq protein alpha subunit mRNA expression in human monocytes: relevance of the purification step | 1.5 | 2 | Citations (PDF) |
| 947 | Role of inspectors in external review mechanisms: criteria for selection, training and appraisal | 1.5 | 24 | Citations (PDF) |
| 948 | IVD industry role for quality and accreditation in medical laboratories | 1.5 | 11 | Citations (PDF) |
| 949 | External Quality Assessment Schemes: need for recognised requirements | 1.5 | 28 | Citations (PDF) |
| 950 | Biochemical markers of cardiac damage: from efficiency to effectiveness | 1.5 | 27 | Citations (PDF) |
| 951 | Point-of-care testing of cardiac markers: results from an experience in an Emergency Department | 1.5 | 32 | Citations (PDF) |
| 952 | Colorectal cancer metastatic phenotype stimulates production by fibroblasts of N-terminal peptide of type III collagen: clinical implications for prognosis | 1.5 | 10 | Citations (PDF) |
| 953 | Biomarkers for afrophic chronic gastritis diagnosis in a dyspeptic european population | 0.9 | 0 | Citations (PDF) |
| 954 | Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer | 0.9 | 0 | Citations (PDF) |
| 955 | IBS patients complaining of adverse reaction to flour have unrecognized IgE to prolamins from wheat | 0.9 | 0 | Citations (PDF) |
| 956 | Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? | 1.7 | 19 | Citations (PDF) |
| 957 | Effects of Cyclosporin A on Human Conjunctival Fibroblasts | 2.2 | 52 | Citations (PDF) |
| 958 | IgE binding to soluble and insoluble wheat flour proteins in atopic and non‐atopic patients suffering from gastrointestinal symptoms after wheat ingestion | 2.4 | 72 | Citations (PDF) |
| 959 | Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern | 1.4 | 37 | Citations (PDF) |
| 960 | Role of anti‐transglutaminase (anti‐tTG), anti‐gliadin, and anti‐endomysium serum antibodies in diagnosing celiac disease: A comparison of four different commercial kits for anti‐tTG determination | 2.7 | 22 | Citations (PDF) |
| 961 | Length of Sedimentation Reaction in Undiluted Blood (Erythrocyte Sedimentation Rate): Variations with Sex and Age and Reference Limits | 2.3 | 52 | Citations (PDF) |
| 962 | Warm Hepatic Ischemia in Pigs: Effects of L-Arginine and Oligotide Treatment | 2.3 | 8 | Citations (PDF) |
| 963 | URINARY EPIDERMAL GROWTH FACTOR IN DIFFERENT RENAL CONDITIONS IN CHILDREN | 2.5 | 6 | Citations (PDF) |
| 964 | Urokinase type plasminogen activator and inhibitor type-1 plasma levels in colorectal cancer | 0.9 | 1 | Citations (PDF) |
| 965 | Biomarkers for afrophic chronic gastritis diagnosis in a dyspeptic european population | 0.9 | 0 | Citations (PDF) |
| 966 | IBS patients complaining of adverse reaction to flour have unrecognized IgE to prolamins from wheat | 0.9 | 0 | Citations (PDF) |
| 967 | Beta Endorphin Concentrations in Human Milk | 2.2 | 0 | Citations (PDF) |
| 968 | Antigastric autoantibodies inHelicobacter pylori infection: role in gastric mucosal inflammation | 1.0 | 14 | Citations (PDF) |
| 969 | Interleukin-6 Blood Level Is Associated With Circulating Carcinoembryonic Antigen and Prognosis in Patients With Colorectal Cancer | 2.3 | 183 | Citations (PDF) |
| 970 | Effect of patent ductus arteriosus and indomethacin treatment on serum cardiac troponin T levels in preterm infants with respiratory distress syndrome | 2.1 | 19 | Citations (PDF) |
| 971 | Hemolyzed Specimens: A Reason for Rejection or a Clinical Challenge? | 1.1 | 189 | Citations (PDF) |
| 972 | Rapid Measurement of Cardiac Markers on Stratus CS | 1.1 | 51 | Citations (PDF) |
| 973 | Multicenter Evaluation of Five Assays for Myoglobin Determination | 1.1 | 20 | Citations (PDF) |
| 974 | Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model | 3.8 | 46 | Citations (PDF) |
| 975 | Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases | 3.8 | 109 | Citations (PDF) |
| 976 | External quality assessment of urine analysis in Europe | 1.5 | 6 | Citations (PDF) |
| 977 | Biological variability in assessing the clinical value of biochemical markers of bone turnover | 1.5 | 24 | Citations (PDF) |
| 978 | ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications | 1.5 | 13 | Citations (PDF) |
| 979 | Proteases in gastrointestinal neoplastic diseases | 1.5 | 58 | Citations (PDF) |
| 980 | Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: which is clinically effective and when? | 1.4 | 34 | Citations (PDF) |
| 981 | The prognostic impat of urokinase type plasminogen activator receptor in colorectal cancer | 0.9 | 0 | Citations (PDF) |
| 982 | Usefulness of EC4 Essential Criteria for Quality Systems of Medical Laboratories as Guideline to the ISO 15189 and ISO 17025 Documents | 2.3 | 25 | Citations (PDF) |
| 983 | C-reactive Protein and Serum Amyloid A protein in Neonatal Infections | 1.5 | 47 | Citations (PDF) |
| 984 | Determination of Serum Eosinophil Cationic Protein, Eosinophil Count, and Total IgE in Children with Different Severities of Atopic Diseases | 0.2 | 2 | Citations (PDF) |
| 985 | Metastatic colo-rectal cancer cells stimulate collagen production by fibroblasts | 0.9 | 0 | Citations (PDF) |
| 986 | Gene therapy with HSV-TK of pancreatic cancer cell lines: Different responses to GCV treatment | 0.9 | 1 | Citations (PDF) |
| 987 | K-ras point mutations detection in pancreatic cancer serum and bile-derived DNA | 0.9 | 0 | Citations (PDF) |
| 988 | High serum cardiac troponin T concentrations in preterm infants with respiratory distress syndrome* | 1.6 | 4 | Citations (PDF) |
| 989 | Evaluation of Glycated Globins by Matrix-assisted Laser Desorption/Ionization Mass Spectrometry | 1.1 | 41 | Citations (PDF) |
| 990 | Cystatin C in Healthy Women at Term Pregnancy and in their Infant Newborns: Relationship Between Maternal and Neonatal Serum Levels and Reference Values | 1.6 | 95 | Citations (PDF) |
| 991 | Cardiac Markers: Centralized or Decentralized Testing? | 2.3 | 10 | Citations (PDF) |
| 992 | Reference Intervals: Are Interlaboratory Differences Appropriate? | 2.3 | 18 | Citations (PDF) |
| 993 | Polymorphonuclear Oxidative Burst after Helicobacter pylori Water Extract Stimulation Is not Influenced by the Cytotoxic Genotype but Indicates Infection and Gastritis Grade | 2.3 | 4 | Citations (PDF) |
| 994 | Assessment of Package Inserts for Diagnostic Kits | 2.3 | 5 | Citations (PDF) |
| 995 | The Changing Face of Clinical Laboratories | 2.3 | 27 | Citations (PDF) |
| 996 | CYTOKINES AND THE PROGRESSION OF LIVER DAMAGE IN EXPERIMENTAL BILE DUCT LIGATION | 2.2 | 49 | Citations (PDF) |
| 997 | The Italian way: Accreditation and continuous quality improvement in clinical laboratories | 0.8 | 0 | Citations (PDF) |
| 998 | Effect of cagA Status on the Sensitivity of Enzyme Immunoassay in Diagnosing Helicobacter pylori-Infected Children | 3.8 | 11 | Citations (PDF) |
| 999 | Cardiac markers: present and future | 1.0 | 29 | Citations (PDF) |
| 1000 | Rapid determination of creatinine in serum and urine by ion-pair high-performance liquid chromatography | 1.0 | 24 | Citations (PDF) |
| 1001 | Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN | 4.1 | 15 | Citations (PDF) |
| 1002 | An Immunological Evaluation of Type II Diabetic Patients with Periodontal Disease | 2.4 | 19 | Citations (PDF) |
| 1003 | The role of cysteine and serine proteases in colorectal carcinoma | 4.0 | 103 | Citations (PDF) |
| 1004 | Direct evaluation of glycated and glyco-oxidized globins by matrix-assisted laser desorption/ionization mass spectrometry 1999, 13, 8-14 | | 35 | Citations (PDF) |
| 1005 | Immunoturbidimetric assay of glycated hemoglobin | 2.7 | 35 | Citations (PDF) |
| 1006 | Serum antibodies anti-H. pylori and anti-CagA: A comparison between four different assays | 2.7 | 17 | Citations (PDF) |
| 1007 | The laboratory and the general practitioner | 1.5 | 6 | Citations (PDF) |
| 1008 | The clinical importance of laboratory reasoning | 1.5 | 45 | Citations (PDF) |
| 1009 | Predictive markers of pre‐eclampsia in hypertensive disorders of pregnancy | 1.8 | 25 | Citations (PDF) |
| 1010 | Histamine Effects on Conjunctival Fibroblasts from Patients with Vernal Conjunctivitis | 2.5 | 66 | Citations (PDF) |
| 1011 | Glucose Metabolic Alterations in Isolated and Perfused Rat Hepatocytes Induced by Pancreatic Cancer Conditioned Medium: A Low Molecular Weight Factor Possibly Involved | 2.1 | 38 | Citations (PDF) |
| 1012 | Strategies for the Early Diagnosis of Acute Myocardial Infarction Using Biochemical Markers | 0.7 | 38 | Citations (PDF) |
| 1013 | The Authors’ Reply | 0.7 | 3 | Citations (PDF) |
| 1014 | Cytokines Modulate MIA PaCa 2 and CAPAN-1 Adhesion to Extracellular Matrix Proteins | 0.9 | 23 | Citations (PDF) |
| 1015 | Lipoprotein(a) in Acromegaly | 9.6 | 21 | Citations (PDF) |
| 1016 | Pathogenesis of Idiopathic Calcium Nephrolithiasis | 4.2 | 0 | Citations (PDF) |
| 1017 | A proposal for standardizing urine collections for bone resorption markers measurement 1998, 12, 145-149 | | 12 | Citations (PDF) |
| 1018 | Bone metabolism in orthotopic liver transplantation: A prospective study | 3.0 | 49 | Citations (PDF) |
| 1019 | Early prognostic biochemical indicators of fulminant hepatic failure | 1.0 | 9 | Citations (PDF) |
| 1020 | Evaluation of antidiuretic hormone before and after long-term treatment with desmopressin in a group of enuretic children | 3.2 | 12 | Citations (PDF) |
| 1021 | Diagnostic strategies using myoglobin measurement in myocardial infarction | 1.5 | 65 | Citations (PDF) |
| 1022 | Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer | 1.5 | 14 | Citations (PDF) |
| 1023 | Serum pepsinogens A and C in monitoring Helicobacter pylori (Hp) status after the cure: A prospective 4 year study | 0.9 | 2 | Citations (PDF) |
| 1024 | Cysteine and serine proteases in colorectal cancer | 0.9 | 2 | Citations (PDF) |
| 1025 | Procollagens and Inflammatory Cytokine Concentrations in Tarsal and Limbal Vernal Keratoconjunctivitis | 2.5 | 81 | Citations (PDF) |
| 1026 | Quantitative Automated Particle-Enhanced Immunonephelometric Assay for the Routinary Measurement of Human Cystatin C | 2.3 | 70 | Citations (PDF) |
| 1027 | Renal Tolerability of Teicoplanin in a Case of Neonatal Overdose | 1.5 | 17 | Citations (PDF) |
| 1028 | Helicobacter pylori Cytotoxic Genotype Is Associated With Peptic Ulcer and Influences Serology | 0.7 | 37 | Citations (PDF) |
| 1029 | Pathogenesis of Idiopathic Calcium Nephrolithiasis: Update 1997 | 5.4 | 14 | Citations (PDF) |
| 1030 | Is Serum Cystatin C a Sensitive Marker of Glomerular Filtration Rate (GFR)? A Preliminary Study on Renal Transplant Patients | 2.5 | 70 | Citations (PDF) |
| 1031 | The TEST 1 Automated System: A New Method for Measuring the Erythrocyte Sedimentation Rate | 0.7 | 65 | Citations (PDF) |
| 1032 | Measurement of specific immunoglobulin E: intermethod comparison and standardization | 1.1 | 40 | Citations (PDF) |
| 1033 | Helicobacter pylori Cytotoxic Genotype Is Associated With Peptic Ulcer and Influences Serology | 0.7 | 0 | Citations (PDF) |
| 1034 | Endothelial Cell-Associated Tissue Factor Pathway Inhibitor (TFPI) Antigen in Severe Nondiabetic Obese Patients: Effect of Hyperinsulinemia | 2.5 | 6 | Citations (PDF) |
| 1035 | Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis | 3.8 | 58 | Citations (PDF) |
| 1036 | Carboxypeptidase N and Creatine Kinase-MB Isoforms in Acute Myocardial Infarction | 2.3 | 3 | Citations (PDF) |
| 1037 | An Unidentified Pancreatic Cancer Cell Product Alters Some Intracellular Pathways of Glucose Metabolism in Isolated Rat Hepatocytes | 0.9 | 36 | Citations (PDF) |
| 1038 | Somatostatin inhibits the stimulatory effect of secretin on pancreatic cancer cell growth in vitro | 2.2 | 0 | Citations (PDF) |
| 1039 | Mistakes in a stat laboratory: types and frequency | 1.1 | 495 | Citations (PDF) |
| 1040 | Phagocytic Activity of Bronchoalveolar Lavage Neutrophils in Intensive Care Unit Patients on Mechanical Ventilation | 4.0 | 2 | Citations (PDF) |
| 1041 | Respiratory Burst of Neutrophils in Diabetic Patients with Periodontal Disease | 4.0 | 24 | Citations (PDF) |
| 1042 | Helicobacter pyloriGenotypes Inf luence Serum Pepsinogen C Levels | 3.8 | 4 | Citations (PDF) |
| 1043 | Title is missing! | 2.6 | 43 | Citations (PDF) |
| 1044 | N-terminal peptide of Type III procollagen 1997, 79, 1299-1303 | | 4 | Citations (PDF) |
| 1045 | A Highly Specific Method for the Characterization of Glycation and Glyco-oxidation Products of Globins | 1.4 | 33 | Citations (PDF) |
| 1046 | A 3-Year Pilot Study with 1,25-Dihydroxyvitamin D, Calcium, and Calcitonin for Severe Osteodystrophy in Primary Biliary Cirrhosis | 2.3 | 59 | Citations (PDF) |
| 1047 | ALLERGY DIAGNOSIS | 1.1 | 1 | Citations (PDF) |
| 1048 | Efficacy of a pancreatic enzyme formulation in the treatment of steatorrhea in patients with chronic pancreatitis | 1.3 | 10 | Citations (PDF) |
| 1049 | Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy | 0.9 | 22 | Citations (PDF) |
| 1050 | Fluoroenzymometric method to measure cardiac troponin I in sera of patients with myocardial infarction | 1.1 | 50 | Citations (PDF) |
| 1051 | Serum Neurotensin in Human Pancreatic Cancer | 1.4 | 6 | Citations (PDF) |
| 1052 | Gastric Juice Polymerase Chain Reaction: An Alternative to Histology in the Diagnosis of Helicobacter pylori Infection | 3.8 | 20 | Citations (PDF) |
| 1053 | Low molecular mass proteins and urinary enzymes in amniotic fluid of healthy pregnant women at progressive stages of gestation | 1.8 | 17 | Citations (PDF) |
| 1054 | Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2 | 1.0 | 102 | Citations (PDF) |
| 1055 | Cytokines may influence tumor growth and spread | 1.0 | 5 | Citations (PDF) |
| 1056 | Serum procollagen type III peptide in chronic hepatitis B | 1.0 | 26 | Citations (PDF) |
| 1057 | Serum tumor markers in colorectal cancer staging, grading, and follow-up 1996, 62, 239-244 | | 27 | Citations (PDF) |
| 1058 | Serum pepsinogen C: A useful marker of Helicobacter pylori eradication? 1996, 10, 1-5 | | 12 | Citations (PDF) |
| 1059 | New and traditional serum markers of bone metabolism in the detection of skeletal metastases | 1.8 | 33 | Citations (PDF) |
| 1060 | beta-Endorphin in Plasma and Monocytes in Juvenile Headache | 3.0 | 9 | Citations (PDF) |
| 1061 | Receiver-operating characteristic (ROC) curves: a fundamental tool for improving the clinical usefulness of in vitro IgE tests | 6.7 | 17 | Citations (PDF) |
| 1062 | Helicobacter pylori eradication and serum pepsinogens. | 16.8 | 4 | Citations (PDF) |
| 1063 | Pancreatic Exocrine Involvement in Primary Sjogren's Syndrome | 1.4 | 14 | Citations (PDF) |
| 1064 | Gastric Antioxidant, Nitrites, and Mucosal Lipoperoxidation in Chronic Gastritis and Helicobacter pylori Infection | 2.3 | 81 | Citations (PDF) |
| 1065 | Effects of Pancreaticobiliary Duct Obstruction on the Exocrine and Endocrine Rat Pancreas | 0.9 | 16 | Citations (PDF) |
| 1066 | Cysteine and serine proteases in gastric cancer | 4.0 | 53 | Citations (PDF) |
| 1067 | Urinary gonadotropin peptide: Collection of specimens and cutoff levels | 2.7 | 1 | Citations (PDF) |
| 1068 | Evaluation of a new automated system for the determination of ck-mb isoforms | 2.7 | 12 | Citations (PDF) |
| 1069 | Gastrin stimulates gastric mast cells in rabbits | 0.0 | 6 | Citations (PDF) |
| 1070 | Insulin-like growth factor-I, interleukin-1 α and β in pancreatic cancer: role in tumor invasiveness and associated diabetes | 1.0 | 32 | Citations (PDF) |
| 1071 | International normalized ratio: merits, limits and improvements | 1.0 | 1 | Citations (PDF) |
| 1072 | Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis | 6.7 | 97 | Citations (PDF) |
| 1073 | Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? | 5.5 | 76 | Citations (PDF) |
| 1074 | ALTERED LIPID PEROXIDATION/GLUTATHIONE RATIO IN EXPERIMENTAL EXTRAHEPATIC CHOLESTASIS | 2.2 | 27 | Citations (PDF) |
| 1075 | Full automation in allergy testing: measurement of specific IgE by the ENEA System | 6.7 | 9 | Citations (PDF) |
| 1076 | Influence ofHelicobacter pylori on tryptase and cathepsin D in peptic ulcer | 2.1 | 8 | Citations (PDF) |
| 1077 | Laboratory test scores to aid identification of primary nonfunction of liver transplants | 1.1 | 6 | Citations (PDF) |
| 1078 | Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art | 1.9 | 21 | Citations (PDF) |
| 1079 | Quantitative cytochemistry of human leukocyte elastase compared with plasma elastase and acute phase proteins in inflammatory diseases | 1.5 | 5 | Citations (PDF) |
| 1080 | Early drop in anti Helicobacter pylori IgG titre after eradication therapy with clarithromycin | 0.9 | 1 | Citations (PDF) |
| 1081 | Serum pepsinogen A and C levels: A follow-up study on 476 patients after Helicobacter pylori eradication | 0.9 | 0 | Citations (PDF) |
| 1082 | Gastric juice polymerase chain reaction (PCR) for Helicobacter pylori (Hp) diagnosis: An alternative to histology? | 0.9 | 0 | Citations (PDF) |
| 1083 | Coagulation and plasma fibronectin parameters in HELLP syndrome | 1.8 | 34 | Citations (PDF) |
| 1084 | Role of epidermal growth factor, interleukin-1 and lipid peroxidation in healing of experimental gastric ulcer in rats | 2.2 | 1 | Citations (PDF) |
| 1085 | Cytokines and progression of liver damage in experimental bile duct ligation | 0.9 | 0 | Citations (PDF) |
| 1086 | Are tryptase and cathepsin D related toHelicobacter pylori infection and mucosal gastrin in peptic ulcer? | 0.0 | 4 | Citations (PDF) |
| 1087 | In Vitro Exposure to Nitrogen Dioxide (NO2) Does Not Alter Bronchial Smooth Muscle Responsiveness in Ovalbumin-sensitized Guinea-pigs | 1.1 | 4 | Citations (PDF) |
| 1088 | Laboratory medicine in ulcer disease | 1.8 | 0 | Citations (PDF) |
| 1089 | A new immunoassay for the measurement of myoglobin in serum | 2.7 | 11 | Citations (PDF) |
| 1090 | A new method for detecting anti Helicobacter pylori antibodies: An analytical and clinical evaluation | 2.7 | 2 | Citations (PDF) |
| 1091 | Helicobacter pylori activates gastric mucosal mast cells | 2.1 | 11 | Citations (PDF) |
| 1092 | Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease | 2.1 | 24 | Citations (PDF) |
| 1093 | Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease | 2.1 | 3 | Citations (PDF) |
| 1094 | Eosinophil cationic protein (ECP), histamine and tryptase in peripheral blood before and during inhalation challenge with toluene diisocyanate (TDI) in sensitized subjects | 2.4 | 13 | Citations (PDF) |
| 1095 | Tubular proteins and enzyme content in the amniotic fluid | 0.9 | 8 | Citations (PDF) |
| 1096 | Bonsai: A new allergenic source | 6.1 | 1 | Citations (PDF) |
| 1097 | Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase | 1.5 | 21 | Citations (PDF) |
| 1098 | Identification of subcellular targets and sensitive tests of ethanol-induced damage in isolated rat gastric mucosal cells | 0.9 | 29 | Citations (PDF) |
| 1099 | Bone density and calcium metabolism in patients with long-standing, quiescent Crohnʼs disease | 1.3 | 19 | Citations (PDF) |
| 1100 | β-Cell Function in Pancreatic Adenocarcinoma | 0.9 | 38 | Citations (PDF) |
| 1101 | Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa‐2A interferon | 0.0 | 32 | Citations (PDF) |
| 1102 | BILIARY HYPERPRESSURE IN RAT EXTRAHEPATIC CHOLESTASIS ALTERS HORSERADISH PEROXIDASE BILIARY EXCRETION | 2.2 | 0 | Citations (PDF) |
| 1103 | Effect of beclomethasone dipropionate nasal aerosol on serum markers of bone metabolism in children with seasonal allergic rhinitis | 2.4 | 17 | Citations (PDF) |
| 1104 | Concentrated ascitic fluid reinfusion after cascade filtration in tense ascites | 2.1 | 13 | Citations (PDF) |
| 1105 | Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat | 2.1 | 27 | Citations (PDF) |
| 1106 | Blood pepsinogen as a subclinical marker for duodenal ulcer | 1.3 | 0 | Citations (PDF) |
| 1107 | Hemorrhagic duodenal ulcer disease: Clinical and biochemical findings in a case-control pilot study | 1.3 | 1 | Citations (PDF) |
| 1108 | Bioequivalence of deflazacort and prednisone in the treatment of idiopathic nephrotic syndrome | 1.3 | 3 | Citations (PDF) |
| 1109 | Effects of nizatidine on gastric acid and bicarbonate secretion | 1.3 | 0 | Citations (PDF) |
| 1110 | Serum and salivary caffeine clearance in cirrhosis. Any role in selection for surgery and timing for transplantation? | 4.2 | 6 | Citations (PDF) |
| 1111 | Toluene diisocyanate-stimulated release of arachidonic acid metabolites in the organ bath from guinea-pig airways | 1.1 | 3 | Citations (PDF) |
| 1112 | Pepsinogens in Health and Disease | 5.4 | 45 | Citations (PDF) |
| 1113 | Chronic nicotine intake causes vascular dysregulation in the rat gastric mucosa. | 16.8 | 15 | Citations (PDF) |
| 1114 | Aspartic proteinases and gastrin in the diagnosis of gastric cancer and gastric precancerous changes | 1.3 | 3 | Citations (PDF) |
| 1115 | Theophylline inhibits late asthmatic reactions induced by toluene diisocyanate in sensitised subjects | 1.1 | 4 | Citations (PDF) |
| 1116 | Glutathione, protein sulfhydryls and cysteine proteases in gastric mucosal injury and protection | 1.5 | 95 | Citations (PDF) |
| 1117 | Measurement of tryptase in endoscopic gastroduodenal biopsies: distribution and relationship with ulcer disease | 1.5 | 6 | Citations (PDF) |
| 1118 | Alterations in bilirubin metabolism during extra- and intrahepatic cholestasis | 0.4 | 17 | Citations (PDF) |
| 1119 | Urinary phospholipase A2 excretion in chronic pancreatic diseases | 1.0 | 7 | Citations (PDF) |
| 1120 | Acute reflux pancreatitis in rats: A comparison between two experimental models | 0.0 | 0 | Citations (PDF) |
| 1121 | Extra‐hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases | 3.0 | 26 | Citations (PDF) |
| 1122 | Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal ulcer disease | 1.8 | 5 | Citations (PDF) |
| 1123 | Hepatic Changes and Serum Ferritin in Pancreatic Cancer and other Gastrointestinal Diseases: The Role of Cholestasis | 1.7 | 19 | Citations (PDF) |
| 1124 | Effect of storage time on peptic activity in gastric biopsies | 1.1 | 0 | Citations (PDF) |
| 1125 | Comparison of Two Newly Identified Tumor Markers (CAR-3 AND DU-PAN-2) with CA 19-9 in Patients with Pancreatic Cancer | 1.4 | 5 | Citations (PDF) |
| 1126 | Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes | 1.8 | 13 | Citations (PDF) |
| 1127 | Biochemical markers of hepatic fibrosis | 1.8 | 89 | Citations (PDF) |
| 1128 | CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? | 4.3 | 13 | Citations (PDF) |
| 1129 | Fluorescence Polarization Immunoassay for Cyclosporine A Determination in Whole Blood | 1.8 | 4 | Citations (PDF) |
| 1130 | Measurement of melatonin in blood by radioimmunoassay | 0.9 | 13 | Citations (PDF) |
| 1131 | Eicosanoid release from human bronchial epithelial cells upon exposure to toluene diisocyanate in vitro | 4.1 | 19 | Citations (PDF) |
| 1132 | Leukotriene B4 and late asthmatic reactions induced by toluene diisocyanate | 2.8 | 44 | Citations (PDF) |
| 1133 | Measurement of pepsinogen group I in endoscopic gastroduodenal biopsies | 1.1 | 7 | Citations (PDF) |
| 1134 | Radioimmunoassay for pepsinogen C | 1.1 | 3 | Citations (PDF) |
| 1135 | Oxygen derived free radicals in patients with chronic pancreatic and other digestive diseases. | 1.7 | 29 | Citations (PDF) |
| 1136 | CA 19-9 and CA 125 Determination by Immunoluminometric Assay | 2.3 | 0 | Citations (PDF) |
| 1137 | Biochemical markers of hepatic fibrosis in primary biliary cirrhosis | 0.2 | 17 | Citations (PDF) |
| 1138 | Cryptogenic chronic active liver disease. Evaluation of serum aminoterminal peptide of type III procollagen as a marker of histological activity | 0.2 | 6 | Citations (PDF) |
| 1139 | Serum tissue polypeptide antigen in pancreatic cancer and other gastrointestinal diseases. | 1.7 | 4 | Citations (PDF) |
| 1140 | Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases | 0.1 | 4 | Citations (PDF) |
| 1141 | Letter to the editor | 4.3 | 3 | Citations (PDF) |
| 1142 | High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay | 3.7 | 2 | Citations (PDF) |
| 1143 | Evaluation of the incstar cyclo-trac sp kit for the determination of cyclosporine in blood | 1.8 | 5 | Citations (PDF) |
| 1144 | β-Endorphin levels after experimental blood loss in human subjects. Correlations with cortisol, ACTH, plasma renin activity, plasma catecholamines and blood pressure variations | 2.8 | 9 | Citations (PDF) |
| 1145 | Two new serum immunoassays (RIA and EIA) for the determination of M2 antimitochondrial antibodies in primary biliary cirrhosis | 1.5 | 3 | Citations (PDF) |
| 1146 | Caffeine as indicator of metabolic functions of microsomal liver enzymes | 1.5 | 11 | Citations (PDF) |
| 1147 | Dose-dependent inhibitory effect of inhaled beclomethasone on late asthmatic reactions and increased responsiveness to methacholine induced by toluene diisocyanate in sensitised subjects | 1.1 | 19 | Citations (PDF) |
| 1148 | Role of serum pepsinogen in detecting ulcer disease | 1.5 | 8 | Citations (PDF) |
| 1149 | Influence of isoenzyme patterns on commutability in enzyme determinations | 1.5 | 3 | Citations (PDF) |
| 1150 | Relationship between psychosocial factors and serum level of pepsinogen group I and gastrinemia in the normal subject | 1.1 | 4 | Citations (PDF) |
| 1151 | Assay of pancreatic amylase with use of monoclonal antibodies evaluated. | 1.1 | 11 | Citations (PDF) |
| 1152 | A rapid, specific enzyme immunoassay for follitropin and lutropin determination. | 1.1 | 1 | Citations (PDF) |
| 1153 | Bronchoalveolar Neutrophilia during Late Asthmatic Reactions Induced by Toluene Diisocyanate | 3.2 | 288 | Citations (PDF) |
| 1154 | The Effect of Theophylline on Methacholine and Exercise-Induced Bronchoconstriction in Asthmatic Children | 0.2 | 0 | Citations (PDF) |
| 1155 | Prednisone inhibits late asthmatic reactions and airway inflammation induced by toluene diisocyanate in sensitized subjects | 6.1 | 60 | Citations (PDF) |
| 1156 | Absolute and Relative Bioavailability of a Slow Release Theophylline Preparation in Asthmatic Children | 1.3 | 0 | Citations (PDF) |
| 1157 | Immunoglobulin A (lambda chains) conjugated with lactate dehydrogenase in serum. | 1.1 | 6 | Citations (PDF) |
| 1158 | Glycated serum protein determination: Comparison between thiobarbituric acid and fructosamine assays | 0.2 | 2 | Citations (PDF) |
| 1159 | Effect of 3-hydroxy-3-methylglutarate treatment on plasma ketone bodies, triglycerides, and HDL-cholesterol in streptozotocin-diabetic rats | 1.8 | 3 | Citations (PDF) |
| 1160 | CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis | 4.0 | 66 | Citations (PDF) |
| 1161 | Is Maximal Acid Output Useful in Identifying Relapsing Duodenal Ulcer Patients? | 2.3 | 5 | Citations (PDF) |
| 1162 | Enzyme immunoassay for pancreatic lipase: Comparison with turbidimetric method in pancreatic diseases | 1.8 | 7 | Citations (PDF) |
| 1163 | Macro creatine kinase type 2: A marker of myocardial damage in infants? | 1.8 | 5 | Citations (PDF) |
| 1164 | Serum elastase 1 in chronic pancreatic disease | 0.1 | 17 | Citations (PDF) |
| 1165 | Fluorescence energy transfer immunoassay of digoxin in serum. | 1.1 | 8 | Citations (PDF) |
| 1166 | Biliary alkaline phosphatase isoenzyme in diagnosis of cholestasis. | 1.1 | 7 | Citations (PDF) |
| 1167 | CPK and CPK-MB in the early diagnosis of acute myocardial infarction and prediction of infarcted area | 1.8 | 9 | Citations (PDF) |
| 1168 | Occurrence of an atypical alkaline phosphatase fraction (“biliary”) in primary liver cancer | 1.8 | 10 | Citations (PDF) |
| 1169 | Actual role of pepsinogen group I in the study of upper gastrointestinal diseases | 1.8 | 12 | Citations (PDF) |
| 1170 | Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: a comparative study in normal subjects and in peptic ulcer patients | 1.8 | 8 | Citations (PDF) |
| 1171 | Creatine Kinase in Biochemical Test Panels | 0.7 | 0 | Citations (PDF) |
| 1172 | Serum Pepsinogen Assays and Gastric Acid Secretion | 0.9 | 2 | Citations (PDF) |
| 1173 | Creatine kinase isoenzyme BB: a marker of gastric cancer? | 1.1 | 5 | Citations (PDF) |
| 1174 | Heparin interferes with albumin determination by dye-binding methods. | 1.1 | 28 | Citations (PDF) |
| 1175 | Title is missing! 0 | | 1 | Citations (PDF) |
| 1176 | Total laboratory automation: fit for its intended purposes? | 2.3 | 9 | Citations (PDF) |
| 1177 | Advancing diagnostic stewardship through claims-based utilization analysis: toward a system-wide vision of diagnostic excellence | 2.3 | 2 | Citations (PDF) |
| 1178 | HCV serology: an unfinished agenda | 2.3 | 0 | Citations (PDF) |
| 1179 | Reference intervals in value-based laboratory medicine: a shift from single-point measurements to metabolic variation-based models | 2.3 | 7 | Citations (PDF) |
| 1180 | Multivariate approaches to improve the interpretation of laboratory data | 2.3 | 2 | Citations (PDF) |
| 1181 | Improving diagnosis in health care: laboratory medicine | 1.3 | 8 | Citations (PDF) |
| 1182 | Counting cells is not enough: toward a global vision for quality and training in hematology | 2.3 | 0 | Citations (PDF) |
| 1183 | Methodological evaluation and clinical interpretation of hs-cTnI and hs-cTnT variations: a reappraisal | 2.3 | 1 | Citations (PDF) |
| 1184 | Strategy of Laboratory Medicine – EFLM Vision | 2.3 | 2 | Citations (PDF) |
| 1185 | Reshaping laboratory medicine through technological advances | 2.3 | 2 | Citations (PDF) |
| 1186 | Automation in value-based laboratory medicine: driving precision, capacity, and better outcomes | 2.3 | 3 | Citations (PDF) |
| 1187 | Effect of a dialysis session on the prognostic values of NT-proBNP, troponins, endothelial damage and inflammation biomarkers | 1.5 | 0 | Citations (PDF) |
| 1188 | Optimizing diagnostic thresholds of total vitamin B12 (B12) for identifying cobalamin deficiency in adults with macrocytic anemia | 2.3 | 0 | Citations (PDF) |
| 1189 | Personalized reference intervals based on biological variation: a critical evaluation of strengths and limitations | 2.3 | 4 | Citations (PDF) |
| 1190 | Laboratory quality indicators: persistent variability despite international harmonization efforts | 2.3 | 0 | Citations (PDF) |
| 1191 | Point-of-care testing in the era of value-based laboratory medicine | 2.3 | 2 | Citations (PDF) |
| 1192 | Measurement units harmonization: “Unity in Units” | 2.3 | 0 | Citations (PDF) |
| 1193 | Establishing the laboratory error database: rationale, methodology, and a practical example | 2.3 | 0 | Citations (PDF) |
| 1194 | Laboratory methods and specimen handling in clinical studies: a persistently neglected issue | 2.3 | 0 | Citations (PDF) |
| 1195 | Albumin-adjusted (“corrected”) calcium should no longer be reported: a position statement from the Joint IOF Working Group and IFCC Committee on Bone Metabolism and EFLM Committee on CKD | 2.3 | 0 | Citations (PDF) |
| 1196 | The complete blood count: data or clinical information? | 2.3 | 0 | Citations (PDF) |
| 1197 | Lot-to-lot variability of a high-sensitivity cardiac troponin I assay: clinical implications | 2.3 | 0 | Citations (PDF) |
| 1198 | Characterizing variation in laboratory medicine data: a comparative analysis of standard deviation and coefficient of variation | 2.3 | 0 | Citations (PDF) |
